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Abstract 
Ellis-van Creveld syndrome (EvC, MIM 225500) is an autosomal recessive disease 
caused by the mutations in EVC or EVC2 genes. Human patients with EvC syndrome 
showed clinical features as short limbs, short ribs, postaxial polydactyly and orofacial 
defects and about 60% of affected individuals showed atrial septum defects. Evc-/- 
mice showed short limbs and short ribs similar with those observed in human patients. 
However, the cardiac phenotype of Evc-/- mice had not been studied. In this study, 
histological analysis was performed in both C57Bl/6J X 129Sv mixed background and 
inbred C57Bl/6J 25 background mouse embryos. No obvious cardiac development 
defects were observed. Parallel to this, the Evc mRNA and Evc protein were also 
analyzed by in situ hybridization and using the lacZ reporter system. X-gal positive 
cells were observed at the dorsal to atrial wall and primary atrial septum in E11.5 and 
E12.5, respectively. No Evc mRNA was detected in developmental heart by in situ 
hybridization by probes located at c.926 to c.1717.  
Previous study demonstrated that Evc and Evc2 protein are localized to the base of 
cilia. In this study, two different methods, deciliation and immuno-TEM, were applied 
to localize the Evc protein more precisely. The deciliation treatment sheared the cilia 
off at the distal end of transition zone and the immunofluorecent staining results 
indicated that the localization of the Evc protein was not beyond the distal end of 
transition zone. In the immuno-TEM experiment, although several factors were 
modified for proper staining, no informative results were obtained from this 
experiment. As the mutations of ciliary proteins might result in malformation of cilia, 
the ciliary structure of chondrocytes were also examined in this study. No structural 
 II
difference was observed in Evc-/- cells comparing to wildtype control. 
The Evc2 protein was undetectable at the base of cilia in MEFs, chondrocytes and 
osteoblasts when Evc protein was absent. The existence of Evc2 protein was 
detected in total lysate Evc-/- cells by western blot, indicating rather than affecting the 
expression of Evc2 protein, Evc plays a role in Evc2 protein correct localization.  
In human fibroblasts, EVC protein was localized to the base of cilia and the nucleus. 
The nuclear localization of Evc protein was never been observed in mouse cells by 
immunofluorescence staining. This inconsistence was examined through subcellular 
fractionation assay. The western blotting results demonstrated that the Evc protein 
exists in the nuclear fraction in the mouse MEFs. Several potential Evc associated 
proteins suggested by yeast two-hybrid study were also examined in subcellular 
fractionation assay. No distribution differences between wildtype and Evc-/- cells were 
observed. 
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Chapter 1 Introduction 
1.1 Ellis-van Creveld (EvC) syndrome 
1.1.1 Clinical features of EvC syndrome 
Ellis-van Creveld syndrome (EvC, MIM 225500) is an autosomal recessive 
disease first reported by Ellis and van Creveld in 1940. This syndrome 
causes progressive shortening of the proximodistal axis of the limbs, with 
zeugopod (radius-ulna/tibia-fibula) shortening more pronounced than the 
stylopod shortening (humerus/femur). Autopod shortening of the distal 
phalanges is more marked than that of the proximal phalanges. 
"Six-fingered dwarfism" is a useful function for defining EvC syndrome, and 
served as an alternative name in the 1960s. This term is no longer used 
because of the polydactyly reference to "freakish" labeling. To date, 
Ellis-van Creveld (abbreviated EvC) is the only satisfactory designation for 
this syndrome. The EvC syndrome is sometimes hard to differentiate from 
two other forms of skeletal dysplasia, asphyxiating thoracic dysplasia or 
Jeune syndrome and short-rib polydactyly syndrome type III, due to the 
overlap of their clinical features. Figures on the worldwide prevalence of 
EvC syndrome is unavailable (Ruiz-Perez and Goodship, 2009; Vinay et al., 
2009). However, the live birth prevalence in the Old Order Amish 
community of Lancaster Country, Pennsylvania is 5 in 1000 (McKusick et 
al., 1964).  
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EvC syndrome is a complex condition involving several developmental 
defects, most of which appear in the skeleton and skin. Patients display a 
wide spectrum of developmental defects, which might vary greatly between 
patients. Common characteristics of the EvC syndrome include short limbs, 
short ribs, postaxial polydactyly (Figure 1.1 A), fingernail dystrophy, 
multiple oral frenula, neonatal teeth, delayed tooth eruption (Figure 1.1 B) 
and cardiac defects (Biggerstaff and Mazaheri, 1968; Ellis and Van Creveld, 
1940; McKusick et al., 1964; Taylor et al., 1984). The finger and toenails 
are small or have an unusual appearance, and the syndrome affects hair in 
some cases. Some EvC patients exhibit craniofacial abnormalities. Other 
patients show multiple labiogingival frenulae, premature eruption of teeth, 
including the presence of teeth at birth, small conical teeth, and missing 
primary or permanent teeth (Ruiz-Perez and Goodship, 2009; Vinay et al., 
2009). 
Approximately 60% of affected individuals suffer from cardiac defects 
(Figure 1.1 C). The most frequent cardiac abnormalities in human patients 
are defects in atrioventricular septation and a single atrium (Digilio et al., 
1999; Katsouras et al., 2003). Previous research reports clinical features 
such as hypoplastic aorta, enlarged pulmonary artery, transposition of 
great vessels, and mitral cleft (da Silva et al., 1980; McKusick et al., 1964). 
In McKusick's study, approximately 50% of the EvC patients were stillbirth 
or died in infancy. This is most likely to be due to the heart defects or 
respiratory problems associated with a short thoracic region (McKusick et 
al., 1964).  
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A 
 
B 
 
C 
 
Figure 1.1 Some clinical features of patients with EvC syndrome 
(A) Bilateral postaxial polydactly (adapted from Ulucan et al., 2008) and (B) 
multiple frenulae and abnormal teeth (adapted from Alves-Pereira et al., 
2009) usually appear in patients with EvC syndrome. (C) Demonstrated 
defects in atrioventricular septation (adapted from Dr. Michael Wright) and 
a single atrium observed in EvC patients.  
 
There is no clinical treatment for patients with EvC syndrome. However, 
some medical and surgical cares are available to improve the quality of 
EvC patients' life. For example, orthopedic procedures can correct 
polydactyly and bone deformities, especially knee valgus with depression 
of the lateral tibial plateau and dislocation of the patella. Surgery is also 
beneficial for patients with periperative morbidity. Some studies 
demonstrate that dental abnormalities, such as peg teeth or natal teeth, are 
more prone to dislodgement during use (Cahuana et al., 2004; Susami et 
al., 1999). However, the mortality rate due to heart failure remains 
significant. Chondrodysplasia of the legs can cause short stature in EvC 
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patients. Treatment with growth hormones is ineffective (Baujat and Le 
Merrer, 2007; Pirazzoli et al., 1989). 
1.1.2 EVC and EVC2 genes 
In 1996, researchers mapped the EvC syndrome to the short arm of 
chromosome 4 between genetic markers D4S2957 and D4S827 in studies 
involving 9 interrelated Amish pedigrees and 3 unrelated families from 
Mexico, Ecuador, and Brazil (Polymeropoulos et al., 1996). In 2000, 
researchers identified a novel gene, EVC, as responsible for EvC 
syndrome (Ruiz-Perez et al., 2000). Mutations of the EVC2 gene appeared 
in an EvC individual from a consanguineous Gypsy family in 2003 
(Ruiz-Perez et al., 2003). Takeda et al. previously mapped the EVC2 gene 
to chromosome 4 under another name, LIMBIN (Takeda et al., 2002). 
Galdzicka et al. reported other mutations in EVC2 in an EvC patient 
(Galdzicka et al., 2002).  
Current knowledge of EVC and EVC2 states that they are arranged in a 
head-to-head divergent configuration with transcription start sites 
separated by only 2,624bp in human and 1,647bp in mouse (Figure 1.2) 
(Ruiz-Perez et al., 2003). Genes with this type of head-to-head 
configuration may be coregulated by a single promoter with bidirectional 
activity (Shimada et al., 1989). 
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Figure 1.2 Human genetic structures of EVC and EVC2 (adapted from 
Tompson et al., 2007) 
EVC and EVC2 genes are located on chromosome 4p in a head-to-head 
configuration. 
 
The longest EVC protein translated from gene contains 21 exons within a 
117kb genomic region, and encodes a protein consisting of 992 amino 
acids. Previous research indicates three more EVC variants 
(http://www.ebi.ac.uk/astd/geneview.html). One of them contains 12 exons 
with the same 5'-end 11 exons and an alternative exon 12. The other two 
are short transcriptions, both of which contain two exons 
(http://www.ebi.ac.uk/astd/geneview.html). Low levels of EVC appear in 
developing bone, heart, kidney, and lung at Carnegie stages 19 and 21 in 
human embryonic tissue using in situ hybridization (Ruiz-Perez et al., 
2000). In bone, EVC mRNA appears in the developing vertebral bodies, 
ribs, and both upper and lower limbs (Ruiz-Perez et al., 2000).  
EVC2 consists of 23 exons, and produces transcripts with at least three 
alternate transcription start sites and three prime ends. Exons 16 and 18 
are also subject to alternative splicing, and have tissue-specific transcripts 
(Galdzicka et al., 2002). Northern blot analysis demonstrates a 4.8kb EVC2 
transcript in heart, placenta, lung, liver skeletal muscle, kidney, and 
pancreas. The 4.8kb transcript also appears in lymphoblasts and 
chondrocytes using reverse transcription polymerase chain reaction 
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RT-PCR (Galdzicka et al., 2002). EVC and EVC2 encode novel proteins 
with putative transmembrane domains and regions of coiled-coiled 
structure, but have no similarity with the motifs of other proteins to give 
clues to their functions (Ruiz-Perez et al., 2000). The functions of EVC and 
EVC2 proteins remain unclear. 
Previous studies report 29 mutations in EVC and 35 mutations in EVC2 in 
patients with EvC syndrome. These mutations include missense/nonsense 
mutations, splicing error mutations, small deletions, small insertions, and 
gross deletions (Galdzicka et al., 2002; Ruiz-Perez et al., 2003; Ruiz-Perez 
et al., 2000; Tompson et al., 2007).  
1.1.3 The other disease caused by the mutations of EVC gene 
Weyers acrofacial dysostosis (MIM 193530) is an autosomal dominant 
disorder also known as Curry-Hall syndrome, as Curry and Hall described a 
large Spanish-Mexican family in 1979 (Curry & Hall, 1979, cited by (Ye et 
al., 2006)). Weyers acrofacial dysostosis shares the same clinical features 
as EvC syndrome, including polydactyly, dysplastic nails, and shortness of 
stature, but in a mild form. The only exception to this rule, reported in 1997, 
involved the proband of a four-generation Weyers acrofacial dysostosis 
family who showed a relatively severe phenotype similar to that of EvC 
(Howard et al., 1997). In 2000, Ruiz-Perez and colleagues reported an EvC 
patient whose father had Weyers acrofacial dysostosis, suggesting an 
overlap in the clinical features of these two diseases. Linkage and 
haplotype analysis indicates that the disease locus of Weyers acrofacial 
dysostosis resides in the genetic markers D4S3007 and D4S2366. This 
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region includes the EVC locus. This finding highlights the possibility that 
Weyers acrofacial dysostosis is allelic to Ellis-van Creveld syndrome 
(Ruiz-Perez et al., 2000). Ye et al. confirmed this hypothesis by reporting 
an EVC2 gene mutation (c.3793delC) in a Weyers acrofacial dysostosis 
family (Ye et al., 2006). 
1.1.4 Evc knockout mice 
A previous study by our research group reports that Evc-/- mice were 
generated by replacing Evc exon 1 with a β-galactosidase gene in an 
in-frame status (Figure 1.3). Absence of Evc transcript in Evc-/- mice was 
confirmed by RT-PCR (Ruiz-Perez et al., 2007).  
 
Wild-type 
 
Evc-/- 
Figure 1.3 Exon1 replacement in Evc-/- mice (adapted from Ruiz-Perez 
et al., 2007) 
The exon 1 of Evc gene was in-frame replaced by LacZ gene, which can be 
used as reporter gene as Evc expression in Evc+/- and Evc-/- mice. 
 
No discernable defects appeared in Evc+/- mice. Although no prenatal loss 
of Evc knockout offspring was detected, approximately half of the Evc-/- 
offspring were missing 2 days after birth (Ruiz-Perez et al., 2007). The 
cause of neonatal death remains unclear. The surviving Evc-/- mutants 
were unable to feed on a normal diet, but were able to survive when 
supplied with soft, well-hydrated food. Evc-/- mice did not breed. Therefore, 
mice were maintained by crossing Evc+/- males to Evc+/- females.  
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Though the Evc-/- mice shared some EvC features of human patients, 
including short ribs, short limbs, and dental anomalies (Figure 1.4), they did 
not exhibit polydactyly. The teeth of Evc-/- mice revealed abnormalities of 
the incisors, including absence of the upper incisors and a single upper 
incisor. Compared with wild type dentition, a small first molar frequently 
appeared in Evc-/- mice (Ruiz-Perez et al., 2007). Furthermore, β-gal 
staining of the Evc-/- mouse embryos and newborn demonstrated that Evc 
expressed in the mouth and tooth-forming area and in the developing 
skeleton. β-gal was also positive at the growth plates of distal and proximal 
tibia in newborn mice. On the other hand, the ossified centers of the long 
bones were-gal negative (Ruiz-Perez et al., 2007). 
 
Wild-type Evc-/-  
 
Figure 1.4 Phenotypes of Evc-/- mice 
(adapted from Ruiz-Perez et al., 2007) 
Developmental defects appeared in Evc-/- 
mice (right panel) compared to the wild-type 
littermate (left panel). The radiographs at 
P18 (upper row) show a small rib cage and 
shortness of long bone in Evc-/- mice (upper 
right). Evc-/- mice also showed the 
abnormalities in incisors (middle right) and 
molars (bottom right). 
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Shortening of the long bones and ribs is one of the major features of EvC 
syndrome. Although skeletal development involves many signaling 
molecules and pathways, Indian hedgehog (IHH) is one of the master 
regulators (Kronenberg, 2003). Previous studies demonstrate a drastic 
reduction of the expression of the Patched homolog 1 (Ptch1) and the 
GLI-Kruppel family member GLI1 (Gli1) in Evc-/- chondrocytes using 
RT-PCR. After exogenous stimulation of the Hedgehog (Hh) pathway with 
purmorphamine, RT-PCR analysis reveals that the RNA expression of 
Ptch1 and Gli1 level was greatly diminished in Evc-/- chondrocytes, 
whereas the wild type expressed both of these mRNA. Both the full-length 
GLI-Kruppel family member GLI3 (GLI3) and GLI3 repressor form in Evc-/- 
E10.5 embryos and E14.5 limb bud were normal in western blotting study. 
Since purmorphamine is an Hh agonist that targets Smoothened (SMO), 
these findings indicate that Evc might participate in the Ihh signaling 
pathway downstream of SMO (Ruiz-Perez et al., 2007).  
Approximately 60% of EvC patients show heart developmental defects, 
implying that EVC plays a role in heart development. Nevertheless, the 
heart development in Evc-/- mice at the beginning of this study and the 
expression of Evc in developmental heart remain unknown. 
1.2 Cardiac development 
1.2.1 Formation of primary heart tubes 
Cardiac development begins as specification of the two bilateral precardiac 
mesodermal cells during embryonic gastrulation. Anterolateral precardiac 
mesodermal cells further differentiate to myocardial and endocardial 
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progenitors, which are generally referred to as the primary heart field. The 
two fields form the cardiac crescent as the embryo folds, and further fuse to 
form the primary heart tube (Tam et al., 1997). The primary heart tube 
consists of outer myocardial cells, inner endocardial cells, and cardiac jelly 
between these two layers (Markwald et al., 1977, cited by (Eisenberg and 
Markwald, 1995)). Heart development proceeds with the elongation of both 
ends of the primary heart tube. At the same time, the heart tube starts to 
loop toward the right (Figure 1.5) (Manner, 2004). 
 
 
Figure 1.5 Schematic view of cardiac development I (adapted from 
High & Epstein, 2008) 
Bilateral heart fields specified at E7.0. As the embryo folds, these two heart 
fields fuse at E7.5 and form a linear heart tube at E8.0. At E8.5, the middle 
part of heart tube starts to loop toward the right. 
 
1.2.2 Heart looping and chamber formation 
To allow looping, the middle part of heart tube disassociates from the body, 
leaving only the caudal and cranial ends of the heart tube connected to the 
body (Drake et al., 2006). The future chamber region also expands, but 
remain connected in series for the moment. From the inflow pole to the 
outflow pole, these regions include the common atrium, left ventricle, and 
right ventricle.  
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1.2.3 Outflow tract (OFT) septation 
As the heart tube loops to the right, cardiac neural crest cells, derived from 
the dorsal neural tube, migrate spirally into the OFT. These cells form the 
OFT cushions together with mesenchymal cells generated by endothelial 
cells through epithelial to mesenchymal transition (Kirby et al., 1983). The 
cardiac neural crest cells collect in two prongs along the truncal OFT 
cushion and abruptly end upon reaching the conal portion of the OFT. The 
distal end of two prongs connect through a shelf of mesenchymal cells that 
protrudes into the dorsal wall of the aortic sac and is located between the 
origins of the fourth and sixth pairs of arch arteries (Waldo et al., 1998). 
The elongation of the shelf at the expense of the prongs separates the 
truncal portion of the OFT into the ascending aorta and pulmonary trunk. 
The fusion of conal OFT cushions and the masculinization of this 
mesenchymal septum separates the aortic and pulmonary outlet 
components (Kruithof et al., 2003; van den Hoff et al., 1999). The formation 
of semi lunar valves through remodeling the OFT mesenchymal tissues 
and the rotation of the OFT wall also occurs during OFT septation. The 
OFT wall rotates counterclockwise through the hypoxia-driven programmed 
cell death of partial distal OFT myocardial wall. This aligns the aorta with 
the left ventricle and pulmonary trunk with the right ventricle (Bajolle et al., 
2006; Sugishita et al., 2004).  
1.2.4 Atrioventricular (AV) septation 
While the heart tube loops towards the right, the cardiac jelly separating the 
myocardial and endocardial cells moves from its original place and 
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accumulates at the AV junction and OFT. The rich regions of the 
extracellular matrix containing cardiac jelly are called cushions. Two major 
cushions, the inferior AV cushion and the superior AV cushion, are involved 
in separating the atria from the ventricles (Figure 1.6). Two minor cushions, 
the left-lateral AV cushion and the right-lateral AV cushion, are involved in 
valve formation later in development (de Lange et al., 2004; Wessels et al., 
1996). The inferior AV cushion and superior AV cushion fuse to form an AV 
mesenchymal septum in the midline of the AV canal, separating the atria 
from the ventricles.  
1.2.5 Atrial septation 
The primary atrial septum, a myocardial strand extending from the dorsal 
atrial wall, divides the common atrium. As the septum descends into the 
atrial cavity, a small mesenchymal tissue cap covers the leading edge of 
the primary atrial septum (Snarr et al., 2007). This cap fuses with the 
superior AV cushion anteriorly and the dorsal mesenchymal protrusion 
posteriorly (Snarr et al., 2007; Wessels et al., 2000). The dorsal 
mesenchymal protrusion is a mesenchymal tissue derived from the 
secondary heart field located in the region anterior and medial to the 
primary heart field. The dorsal mesocardium associated with the dorsal 
mesenchymal protrusion wedges into the atrial cavity from the dorsal atrial 
wall (Wessels et al., 2000). The fusion of the atrial septum, dorsal 
mesenchymal protrusion, and AV cushions separates the left and right 
atria.  
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1.2.6 Ventricular septation 
The growth of the myocardial wall expands the ventricular chambers 
(Christoffels et al., 2000). This expansion accompanies the extension of 
myocardium into the lumen of ventricular chambers. This process forms 
trabeculae and results in the sponge appearance in the ventricular 
chambers (Sedmera et al., 1997). The ventricular septum grows from the 
myocardium at the greater curvature towards the atrioventricular 
mesenchymal septum separating the ventricular chambers (Figure 1.6). 
The membranous septum from the cushions fills the gap between the crest 
of the ventricular septum and atrioventricular septum (Solomon et al., 
1997).  
 
 
Figure 1.6 Schematic view of cardiac development II (adapted from 
High & Epstein, 2008) 
Multiple developmental events occur at E9.5. Although still linearly 
connected, the future four chambers expand. The outflow tract cushions 
and AV cushions start to develop within the heart tube. The trabeculae 
structure also form from the extension of myocardium into the lumen of 
ventricular chambers. 
1.2.7 Valve formation 
The AV valves from cavitation of the AV cushion. The anterosuperior leaflet 
and posterior leaflet of the tricuspid valve develop from the right lateral 
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cushion, while the septal leaflet of the tricuspid valve develops from the 
inferior AV cushion. The mural leaflet of the mitral valve develops from the 
left lateral cushion, and the aortic leaflet of the mitral valve develops from 
the superior AV cushion. Sculpting of the myocardial wall releases the 
valve leaflet from the cushions (de Lange et al., 2004). The distal ends of 
the leaflets attach to the papillary muscles via chordae tendineae. 
1.3 Bone development 
1.3.1 Bone structure  
Bones are hard organs that form the skeletons of vertebrates. They are 
important for the movement, support, and protection of the organs, 
production of red and white blood cells, and storage of minerals 
(Kronenberg, 2003; Standring and Ellis, 2005). Adult humans have 206 
bones, while infants have 270 (Standring and Ellis, 2005). The outer shell 
of long bones is a hard bone called cortical bone. This type of bone 
accounts for 80% of the total bone mass of an adult skeleton. This tissue 
gives bones their smooth, white, and solid appearance. The other 20% of 
bone mass is the interior trabecular bone tissue, an open cell porous 
network also called cancellous or spongy bone that consists of a network of 
rod- and plate-like elements (Standring and Ellis, 2005). Inner bone cavities 
contain marrow that produces blood cells (Standring and Ellis, 2005).  
1.3.2 Bone formation 
Bone formation, or osteogenesis, begins during the prenatal stage and 
continues through adulthood. It occurs either through direct ossification of 
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embryonic connective tissue, called intramembranous ossification 
(Syftestad et al., 1985), or the replacement of hyaline cartilage, called 
intracartilaginous or endochondral ossification (Pelttari et al., 2008). Bones 
formed by intramembranous ossificaion are called membrane bone 
(Syftestad et al., 1985), whereas bones formed by endochondral 
ossification are called cartilage bone (Pelttari et al., 2008). 
1.3.2.1 Types of cells involved in bone development 
References to bones or cartilage commonly call mesenchymal stem cells 
(MSC) osteochondrogenic cells because they can differentiate into 
chondrocytes or osteoblasts (Hall and Miyake, 2000; Pelttari et al., 2008). 
Chondrocytes, the only cells found in cartilage, produce and maintain a 
cartilaginous matrix that consists mainly of proteoglycans and collagen 
(Noonan et al., 1998). Chondrocytes undergo terminal differentiation 
when they become hypertrophic during endochondral ossification 
(Kronenberg, 2003). The two types of cells that play important roles in 
bone formation are osteoblasts and osteoclasts. Osteoblasts, the 
specialized cells in bone tissue, deposit calcium into the bone matrix 
(Seeman, 2008). Osteoclasts dissolve calcium from bones and carry it 
into blood vessels (Hartmann, 2006).  
1.3.2.2 Intramembranous ossification 
Intramembranous ossification occurs primarily in the formation of flat 
bones of the skull (Pelttari et al., 2008). This process creates flat, 
membrane-like layers of early connective tissue, called mesenchyme 
tissue. In early development, blood vessel networks form between the 
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layers to provide a constant flow of nutrients (Pelttari et al., 2008). The 
mesenchymal cells then proliferate and further differentiate into 
osteogenic cells, which are the precursor of osteoblasts (Pelttari et al., 
2008). Osteoblasts remove calcium from the blood and deposit it in the 
bone matrix (Reddi and Anderson, 1976), forming layers of spongy bone 
around the original cartilage (Caetano-Lopes et al., 2007). In later stages 
of development, the space of the sponge bone fills with bone matrix and 
becomes compact bone. This process forms periosteum and compact 
bones (Pelttari et al., 2008). 
1.3.2.3 Intracartilaginous (endochondral) bone formation 
Endochondral ossification occurs in long bones, such as humerus and 
femur (Figure 1.7) (Syftestad et al., 1985). This process forms bone by 
replacing the cartilage model, or precursor, appearing earlier in 
embryonic development (Syftestad et al., 1985). The cartilage models 
first undergo rapid changes as the cartilage cells hypertrophy and the 
cartilage matrix becomes calcified. Following the disintegration of 
calcified matrix, a periosteum forms at the outside of the developing 
structure (Reddi and Anderson, 1976). Blood vessels and undifferentiated 
cells enter the center, disintegrating tissue and forming a primary 
ossification center (Blumer et al., 2008). As a significant amount of 
spongy bone forms, osteoblasts fill portions of the porous spongy bone 
with calcium phosphate crystals to form a bone collar that holds the shaft 
together. This process forms the bone and continues toward both 
epiphyses, the ends of long bones. Interstitial and appositional growth 
increase the amount of cartilage outside the primary ossification center 
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(Hartmann, 2006; Kronenberg, 2003).  
 
Figure 1.7 Intracartilaginous bone formation (adapted from 
Korneneburg HM, 2003) 
(A) Mesenchymal stem cells (MSC) condense. (B) MSC differentiate to 
become chondrocytes (c). (C) Chondrocytes at the center of 
condensation stop proliferating and become hypertrophic chondrocytes 
(h). (D) Chondrocytes adjacent to hypertrophic chondrocytes become 
osteoblasts, forming a bone collar (bc). Hypertrophic chondrocytes direct 
the formation of mineralized matrix, attract blood vessels, and then 
undergo apoptosis. (E) Primary spongiosa (ps) form. (F) Chondrocytes 
continue to proliferate, leading to bone elongation. (G) A secondary 
ossification center (soc) forms. Below the secondary ossification center, a 
growth plate forms orderly columns of proliferating chondrocytes (col). 
Hematopoietic marrow (hm) expands in the marrow space. 
At about the time of birth, a secondary ossification center appears in each 
epiphysis of long bones (Blumer et al., 2008). The growth of a secondary 
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ossification center is similar to that of a primary ossification center 
(Syftestad et al., 1985). The cartilage between the primary and secondary 
ossification centers is called the epiphyseal plate. This is where new 
cartilage forms, elongating the bone (Syftestad et al., 1985). Bone growth 
continues until the cartilage in the plate is completely replaced by bone 
(Kronenberg, 2003; Noonan et al., 1998).  
1.4 Hedgehog signaling pathway 
The hedgehog-signaling pathway is one of the most important key regulators 
of embryo development and conserved from flies to humans. This pathway is 
named from its intercellular signaling molecule in Drosophila, called Hedgehog 
(Hh). Drosophila larvae without this pathway have a hairy appearance 
(Nusslein-Volhard and Wieschaus, 1980). This pathway is vital to establishing 
the body plan and anterior-posterior body segmentation during the later stages 
of development.  
1.4.1 Hedgehog signal in Drosophila – processing 
After translation, the precursor Hh undergoes multiple processing steps for 
the generation and release of the active ligand from the producing cells. 
The signal sequence is firstly removed, and the C-terminal of this precursor 
Hh is then cleaved by an autocatalytic process between conserved Gly257 
and Cys258, generating 19kDa N-terminal domains (HhN) (Lee et al., 
1994). After forming a thioester, the N-terminal Hedgehog signaling domain 
is modified by esterlinking cholesterol to its C-terminus (Porter et al., 1996). 
This cholesterol modification associates HhN with the plasma membrane. 
Finally, the cholesterol-modified HhN molecule matures by adding a 
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palmitic acid moiety to the N-terminus through the acyltransferase activity 
of skinny hedgehog (Chamoun et al., 2001). The active Hh signaling 
molecule thus has cholesterol modification at its C-terminus, and palmitate 
at its N-terminus (Figure 1.8).  
1.4.2 Hedgehog signal in Drosophila – secretion and gradient 
formation  
The mature Hh moves to the cell surface and secreted to form a 
concentration gradient that controls cell differentiation. The secretion of Hh 
from the producing cell requires the activity of dispathed (Disp), a 12 span 
transmembrane protein. Disp is a membrane belonging to the 
resistance-nodulation-division family of transport proteins. Accumulation of 
Hh in the producing cells and failure of long-range signaling appear in Disp 
mutant flies (Burke et al., 1999). 
The distance at which Hh acts is approximately 50 µm in Drosophil wing 
disc. Although the mechanism of Hh transportation remains unclear, this 
process involves heparan sulfate proteoglycan. In Drosophila, cells lacking 
the heparan sulfate synthesizing enzymes of the tout-velu (ttv)/ brother of 
tout velu (botv)/sister of tout velu (sotv) family hinder Hh transportation 
(Bellaiche et al., 1998; Han et al., 2004b; The et al., 1999). Dally and 
Dally-like protein (Dlp), two core proteins of heparan sulfate proteoglycan, 
are vital to the transportation of the Hh signal (Han et al., 2004a). Dally and 
Dlp also facilitate the binding of Hh to the cell surface (Han et al., 2004b; 
Lum et al., 2003).  
When binding to the Hh receptor, Patched, Hh is internalized and targeted 
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with lysosome for degradation (Chen and Struhl, 1996). Patched is another 
Hh signaling targeting gene. With activating the signal pathway, receiving 
cells produce more Patched protein. This negative feedback limits the 
spread of Hh and facilitates the formation of Hh gradient from the secreting 
source. 
1.4.3 Hedgehog signal in Drosophila – signal transduction 
Two transmembrane proteins, iHog and boi, with their fibronectin repeats, 
facilitate the binding of Hedgehog to its receptor, Patched (Ptc) (Yao et al., 
2006). Ptc is a twelve-transmembrane protein that keeps the 
seven-transmembrane protein Smoothed (Smo) in an unphosphorylated 
state when Hedgehog is absent. Endocytosis removes unphosphorylated 
Smo from the membrane, and lysosomes subsequently degrade it (Jia et 
al., 2004; Zhang et al., 2004). The stimulation of Hedgehog results in 
hyperphosphorylation of Smo and subsequent conformation change in C 
terminus of Smo (Zhao et al., 2007). The kinesin-like protein Cos2 that 
binds directly to the C terminus of Smo acts as a scaffolding protein that 
brings together various signal components, including the full-length form of 
transcription activator Ci (CiA), PKA, and kinase Fused (Fu) (Jia et al., 
2003; Lum et al., 2003). PKA hyperphosphorylates CiA in the absence of 
Hh. This hyperphosphorylated CiA is then recognized by ubiquitin E3 ligase 
Slimb and catalyzed into transcription repressor form CiR (Price and 
Kalderon, 2002; Wang et al., 1999). When Smo accumulates and binds to 
Cos2 in response to Hh, it prevents the CiA to CiR conversion (Hooper, 
2003; Jia et al., 2003). Further investigation indicates that the Fu activity is 
required to fully activate the Hh signal by neutralizing the negative effects 
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of Suppressor of Fused (Sufu), which retains some CiA in the cytoplasm 
(Lefers et al., 2001; Ohlmeyer and Kalderon, 1998). 
 
Figure 1.8 Hedgehog signal in Drosophila (adapted from Jiang & Hui, 
2008) 
In the producing cell (right), after autocleavage and cholesterol modification, 
Ski palmitate modifies Hh. The functional Hh is secreted by Disp and 
transported by Dally/Dlp. In the receiving cell, Ihog and Boi facilitate the 
binding to Ptc. The inhibition of Ptc releases Smo and stimulates Ci 
activation from Ci. The activated Ci eventually translocates to the nuclear 
and activates the Hh target genes. 
 
1.4.4 Differences between Drosophila and vertebrate Hh signaling 
The concept of hedgehog signaling transduction in vertebrates is similar to 
that found in Drosophila. One of the major differences is the pathway 
components. There are three different hedgehog homologues in 
vertebrates, including Desert hedgehog (Dhh), Indian hedgehog (Ihh), and 
Sonic hedgehog (Shh) (Echelard et al., 1993). Dhh is mainly expressed in 
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the sertoli cells of the testis, the granulosa cells of the ovaries, and the 
Schwann cells in peripheral nerves. Dhh deficient mice show abnormalities 
in peripheral nerves, with thin perineurial sheaths surrounding the nerve 
fascicles. Male Dhh-/- mice fail to produce mature spermatozoa (Bitgood et 
al., 1996; Wijgerde et al., 2005; Yao et al., 2002). Ihh is expressed in 
primitive endoderm, gut, and prehypertrophic chondrocytes (Dyer et al., 
2001; Vortkamp et al., 1996). In primitive endoderm, Ihh induces the 
formation of hematopoietic and endothelial cells in the adjacent epiblast. 
During gastrulation, Ihh is expressed in the posterior node and the visceral 
endoderm. Poor development of yolk-sac vasculature resulting from 
incomplete expression of Ihh causes a major loss of Ihh-/- embryos in early 
development. The role that Ihh plays in chondrocyte differentiation causes 
aberrant bone development in Ihh-/- mice (St-Jacques et al., 1999). Shh is 
the most widely studied hedgehog molecule. Shh expresses at the node, 
notochord, and floor plate during early embryo development, and controls 
the patterning of left-right and dorso-ventral axes (Sampath et al., 1997; 
Schilling et al., 1999; Watanabe and Nakamura, 2000). Shh expression in 
the polarizing activity zone of the limb controls limb patterning (Chang et al., 
1994). Shh signal is also involved in the development of most epithelial 
tissue during organogenesis.  
Besides the Hedgehog molecules, vertebrate express three Ci homologues, 
Gli1, Gli2 and Gli3 (Hui et al., 1994). Gli1 functions only as a transcriptional 
activator (Hynes et al., 1997). While Gli2 functions mainly as an activator, 
Gli3 functions primarily as a repressor (Ruiz i Altaba, 1998). The 
homologues of Cos2 and Fu that play important roles in the Drosophila Hh 
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signaling pathway also appear in vertebrates. However, there is no 
evidence of their involvement in vertebrate Hedgehog signaling (Chen et al., 
2005; Varjosalo et al., 2006).  
Another difference in the Hedgehog signaling pathway between Drosophila 
and vertebrates is the place at which signal transduction occurs. In 
Drosophila, Hh binding to Ptc triggers the translocation of Smo to the cell 
surface. In vertebrates, in the absence of Hedgehog molecule, Ptch1 
localizes to the primary cilia. Once the signaling pathway is activated, 
Ptch1 translocates away from the cilia and Smo begins to accumulate in 
the cilia. 
1.4.5 Shh signal in vertebrates 
As with Drosophila Hh, Shh is processed into a 20 kDa N-terminal signaling 
domain (Shh-N) and a cholesterol molecule is added to the C-terminal of 
Shh-N. After secretion from the expressing cells, transportation of Shh is 
mediated the HSPG, which requires the heparan sulfate synthesizing 
enzymes of the EXT family (Bellaiche et al., 1998). In the receiving cells, 
Shh binds to its receptor Patched-1 (Ptch1). Two transmembrane proteins, 
Cdo and Boc, facilitate this binding process (homologues of iHog and Boi, 
respectively) (Tenzen et al., 2006). When Shh binds to Ptch1, it releases 
Smoothened (Smo) from inhibitory status and Smo further activates the Gli 
transcription factors by inhibiting the degradation of Gli2 and the proteolytic 
process to generate the repressive form of Gli3 (Figure 1.9).  
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Figure 1.9 Sonic hedgehog signaling pathway (adapted from Bisgrove 
& Yost, 2006) 
The inhibition of Smo stopes when Shh binds to Ptch1. Smo translocates to 
the cilium and controls the proteolytic processing of Gli3 to activator form 
(Gli3A). Shh target genes are transcribed after Gli translocates into the 
nucleus (A). Without Shh, the proteolytic process generates the repressor 
form of Gli3 (Gli3R) which represses the Shh target genes (B). 
 
Previous research reports the conformation change of C terminal of Smo in 
the presence of Hh in mammalian cells (Zhao et al., 2007). Unlike the 
Smo/Ci interaction in Drosophila, the interaction between Smo and Gli 
proteins in mammalian cells is unclear. Recent studies demonstrate that 
small molecules, such as cyclopamine, jervine, oxysterols and vitamin D3 
derivatives, may modulte the activity of Smo (Bijlsma et al., 2006; Chen et 
al., 2002a; Chen et al., 2002b; Dwyer et al., 2007). 
1.4.6 Hedgehog signal & cilium 
Selecting phenotypes suggestive of disrupted Hh signaling in a forward 
genetic screen of N-ethyl-N-nitrosourea (ENU)-induced mutations revealed 
mutations in IFT complex B protein, IFT172, and IFT88 (Huangfu et al., 
2003). Studies on other IFT proteins (IFT52, Kif3a, Kif3b, Dyncb2 and D2lic) 
A B 
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provide further evidence of the involvement of cilium in Hh signaling 
(Haycraft et al., 2005; Huangfu and Anderson, 2005; Huangfu et al., 2003; 
Liu et al., 2005; Rana et al., 2004). The mutation of other genes encoding 
proteins involved in proper ciliogenesis, such as Ofd1 and Arl13b, can also 
disturb Hh signaling (Caspary et al., 2007; Ferrante et al., 2006). These 
findings suggest that primary cilia play an essential role in the Hh pathway. 
Studies on the cellular localization of the components of Hh signal pathway 
provide further evidence of the importance of cilia. Immunofluorescence 
staining results demonstrate that Ptch1, Sufu, and three full length Gli 
proteins localize to the primary cilia (Haycraft et al., 2005; Rohatgi et al., 
2007). Interestingly, Ptch1 leaves the cilia and Smo moves into the cilia in 
the presence of Hh. Corbit and colleagues suggested that the ciliary 
localization of Smo is essential for the activation of the Hh signaling 
pathway (Corbit et al., 2005). However, recent studies on cyclopamine, the 
antagonist of Hh signaling pathway, show that treated MEFs decreased the 
ciliary accumulation of Smo. The authors suggested the ciliary localization 
of Smo is insufficient for the Hh response, and an additional step is 
necessary to active the Hh signaling pathway (Rohatgi et al., 2009; Wilson 
et al., 2009).  
1.4.7 Shh signaling in heart development 
The relationship between Shh signaling and cardiac development was first 
described in 1996 (Chiang et al., 1996). Shh knockout mice showed a 
single OFT arising from the right ventricle, enlarged apex pointing toward 
right, and heart positioned at the left side of the thorax (normally centrally 
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positioned) (Tsukui et al., 1999; Washington Smoak et al., 2005). Other 
studies reported cardiac abnormalities when other components of the 
pathway (Ptch1, Smo, and Sufu) were mutated (Cooper et al., 2005; 
Goodrich et al., 1997; Zhang et al., 2001). 
 
Table 1.1 Summary of cardiac phenotypes of mutant Hh signal 
components  
 Cardiac phenotype Reference 
Shh single outflow tract arising from the right 
ventricle 
enlarged apex pointing toward right 
positioned left in thorax cavity 
atrial septal defect 
Chiang et al., 1996 
Tsukui et al., 1999 
Washington Smoak et al., 
2005 
Ptch1 lethality between E9.0 and E10.5 
the heart is not properly formed 
Goodrich et al., 1997 
Smo lethality around E9.5 
linear heart tube 
Zhang et al., 2001 
Sufu lethality between E9.0 and E10.5 
dilated descending aorta  
abnormal cardiac looping 
Cooper et al., 2005 
 
The cardiac neural crest cells, a subgroup of neural crest cells, is essential 
for cardiovascular development (Kirby et al., 1983). Neural crest cells 
undergo apoptosis in the absence of the Shh signal, indicating the 
necessity of the Shh the survival of neural crest cells in mice (Jeong et al., 
2004). Washington Smoak and colleagues demonstrated that though the 
neural crest cells were correctly specified and migrated into OFT, neural 
crest cells were mislocalized in OFT and underwent apoptosis in Shh-/- 
mouse (Washington Smoak et al., 2005). The tissue specific gene ablation 
study of the Goddeeris group further clarified the role of the Shh signal in 
heart development. The secondary heart field contributes to OFT and right 
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ventricle development and both cardiac neural crest cells and secondary 
heart field are adjacent to pharyngeal endoderm in which Shh is expressed 
during embryonic morphogenesis. Thus, Goddeeris and colleagues posited 
that pharyngeal endoderm SHH expression is crucial for OFT septation 
because it affects cardiac neural crest cells and the secondary heart field 
(Goddeeris et al., 2007). 
In a subsequent study, Goddeeris colleagues demonstrated that the 
secondary heart field derived cells distributed into the dorsal mesenchyme 
and dorsal myocardial wall of the atria at E10.5, the dorsal mesenchymal 
protrusion that wedges into the atria at E11.5, and much of the primary 
atrial septum at E12.5 to E16.5. When Smo was ablated in secondary heart 
field derived cells, the mutant mouse exhibited intracardiac septation 
defects similar to those in Shh-/- mice. These septation defects resulted 
from abnormal dorsal mesenchym differentiation and migration. These 
findings suggest an important role of the secondary heart field in atrial 
septum development (Goddeeris et al., 2008). Hoffmann and colleagues 
identified the migration of Shh responsive cells from the secondary heart 
field into the atrial septum. Further study demonstrates that the Shh signal 
is not necessary for cell migration from secondary heart field into the atrial 
primordium, but is essential for the specification of cardiac progenitors in 
the secondary heart field (Hoffmann et al., 2009). This data indicates that 
atrial septum development requires the proper Shh response in the 
secondary heart field. The disruption of Shh response in the secondary 
heart field could produce atrial septal defects.  
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1.5 Interaction of Wnt and Hedgehog signaling 
1.5.1 Wnt signaling 
The Wnt signaling pathway involves a large number of proteins whose 
interactions regulate embryogenesis (Dickinson and McMahon, 1992; 
Levay-Young and Navre, 1992; McMahon and Bradley, 1990), normal 
physiological processes in adult animals (Gavin et al., 1990; Iozzo et al., 
1995; Sussman et al., 1994; Van Den Berg et al., 1998) and also cancer 
development (Dale et al., 1996; Hart et al., 1998; Iozzo et al., 1995). 
Although the presence and effects of the signaling depend on the Wnt 
ligands, cell types and organisms, some members in the pathway are 
remarkably similar between Caenorhabditis elegans and humans (Cadigan 
and Nusse, 1997; Gavin et al., 1990). The Wnt pathway includes two 
categories: the canonical Wnt pathway and the non-canonical Wnt 
signaling (Moon et al., 2002; Ziemer et al., 2001).  
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Figure 1.10 A schematic diagram of selected components of the 
canonical Wnt signaling (adapted from Nemeth et al., 2007). 
(A) In the absence of the Wnt ligand, the Frizzled receptor, and LRP 5/6 
co-receptor promotes the formation of a complex, including APC, Axin, 
GSK-3β and CK1, that induces the phosphorylation and subsequent 
degradation of β-catenin. In the absence of β-catenin, repressor proteins 
bind to the TCF/LEF transcription factors and prevent the translation of 
downstream genes. (B) In the presence of the Wnt ligand, co-receptors 
LRP5/6 are phosphorylated by membrane-bound casein kinase 1γ and 
GSK-3β. The phosphorylated LRP 5/6 recruit Axin to the cell membrane 
and disrupt the multi-protein complex. Without multi-protein complex, 
β-catenin accumulates and translocates to the nucleus, interacts with 
TCF/LEF, and induces the translation. 
The canonical Wnt pathway begins when Wnt proteins bind to the cell 
surface receptors of the Frizzled family, activating the Disheveled family 
proteins. This consequently stabilizes cytoplasmic β-catenin, which enters 
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the nucleus and promotes specific gene expression (Boutros et al., 2000; 
Habas et al., 2001) (Figure 1.10). Without Wnt proteins, the 
axin/GSK-3/APC complex promotes the proteolytic degradation of the 
β-catenin and inhibits the transcription of downstream genes (Hsu et al., 
1999; Kishida et al., 1998; Willert et al., 1999). Unlike canonical Wnt 
signaling, non-canonical Wnt pathway is β-catenin-independent (Moon et 
al., 2002; Ziemer et al., 2001). 
1.5.2 Interactions of Shh and Wnt signaling 
The Wnt and Shh signaling pathways are critical for the development and 
maturation of many mammalian tissues. However, the interaction between 
these pathways in mammalian systems remains unclear (Alvarez-Medina 
et al., 2008; Borycki et al., 2000; Lei et al., 2006). In patterning the neural 
tube, the Wnt likely works in an indirect inhibitory manner on sonic 
hedgehog. The Wnt signals from the dorsal neural tube function as 
mitogenic signals for neural tube cells (Cayuso and Marti, 2005; Dickinson 
et al., 1994; Megason and McMahon, 2002) and play a role in cell fate 
specification (Muroyama et al., 2002). On the other hand, the activity of the 
Shh from the ventral neural tube is the major signaling pathway, and 
generates distinct classes of neurons in dorsal ventral neural tube (Jessell, 
2000; Stamataki et al., 2005). Several studies on mice and chickens 
demonstrate that Wnt activates and controls the expression of Gli3, one of 
the main inhibitors repressing the transcriptional activity of Shh/Gli in the 
dorsal region of the neural tube, and elicits dorsal cell fates 
(Alvarez-Medina et al., 2008; Borycki et al., 2000; Lei et al., 2006). 
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The Wnt and hedgehog signaling pathways in mice help establish 
boundaries between the oral and dental ectoderm to correctly determine 
the site of tooth formation (Sarkar et al., 2000). Ectopical expression of 
Wnt-7b in presumptive dental ectoderm in the mandibular arch explants 
leads to the down-regulation of the Shh expression in the ectoderm and the 
Ptc expression in the underlying ectomesenchyme, and subsequently 
arrests the tooth development. However, tooth development was complete 
rescue as implantation of beads soaked in Shh protein into Wnt-7b infected 
explants demonstrated the Wnt signaling specifically represses Shh 
signaling (Sarkar et al., 2000). 
The expression of Shh expression is down-regulated in both Lef1 or 
Wnt10b knockout mice, where the Wnt/β-catenin signaling is eliminated 
(Iwatsuki et al., 2007). Organ culture demonstrates that activation of 
Wnt/β-catenin signaling up-regulates the expression of Shh (Iwatsuki et al., 
2007). Furthermore, blocking Shh signaling in cultured tongue explants up 
regulated the Wnt/β-catenin signaling and subsequently enhanced papillae 
formation. This suggests that Wnt/β-catenin signaling plays a central role in 
the development of fungiform papillae and regulating Shh expression, while 
Shh inhibits the Wnt/β-catenin signaling (Iwatsuki et al., 2007). 
Though Wnt and Shh are both important for tissue development, their 
interaction and regulation vary in different tissues (Borycki et al., 2000; 
Iwatsuki et al., 2007; Sarkar et al., 2000). 
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1.6 Cilium 
1.6.1 Ciliary structure 
Cilia, microtubule-based organelles, exist in almost all cells. The two major 
parts of cilia are the basal body and the axoneme. The basal body is 
structurally identical, but adds proteins to one of the centrioles, structures 
that are important components of mitotic spindle and facilitate the proper 
chromosome segregation in cell division. When cells become quiescent, 
centrioles move to the plasma membrane and the mother centriole forms 
the basal body as an anchor point of the later assembled axoneme. The 
axoneme consists of nine peripherally located doublet microtubules with 
(9+2; motile cilia) or without (9+0; primary cilia and nodal cilia) a central 
microtubule pair (Figure 1.11) (Satir, 2005). In motile cilia, the axoneme is a 
9+2 arrangement characterized by the radial spokes and dynein arms that 
contribute to ciliary beating. The most well known cells containing motile 
cilia are the epithelium cells of the respiratory tract, which are responsible 
for moving mucus. Without a central doublet microtubule, primary cilia are 
generally immotile with one exception, the nodal cilia. Although without a 
central microtubule pair, nodal cilia have radial spokes and dynein arms 
and are motile to generate leftward flow in the embryonic node cells during 
development (Nonaka et al., 1998). When the KIF3B protein, an intraciliary 
transport motor, was disrupted in mouse, nodal cilia were absent and the 
establishment of left-right asymmetry was disrupted. Though primary cilia 
were considered a nonfunctional organelle for years, recent studies reveal 
the correlations between primary cilia and human disease. 
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A B 
Figure 1.11 Schematic view of cilium 
(A) The 9+2 cilum (left) was composed of nine outer doublet microtubules 
while the 9+0 cilium (right) lacks the central pair microtubules (adapted 
from Christensen et al., 2007). (B) Transverse view of the 9+2 and 9+0 
cilum shows that the dynein arms and radial spokes associate with 9+2 
cilium and these structures could not be observed in 9+0 cilium (adapted 
from Bisgrove & Yost, 2006). 
1.6.2 Intraflagellar transport 
Elongation of the axoneme from the basal body, ciliogenesis, is completed 
by adding new subunits to the distal tip of the axoneme. As the cilia do not 
synthesize proteins, ciliogenesis depends on a system called intraflagellar 
transport (IFT) to complete the material transport. Kozminski et al. first 
described the IFT system in green alga (Kozminski et al., 1993). At least 15 
polypeptides participate in IFT complexes. The proteins in IFT complexes 
have been grouped into two subsets: complex A containing four or five 
polypeptides and complex B containing at least twelve polypeptides (Cole 
et al., 1998; Piperno et al., 1998). Because the microtubules in cilia are 
oriented with the plus end at the tip of the organelle, two different motors 
are required to complete the movement in the IFT system. The anterograde 
transport (from basal body to cilia tip) of the IFT particles is driven by the 
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heterotrimeric motor Kinesin-2 and the retrograde transport (from cilia tip to 
basal body) depends on the dynein motor (Figure 1.12).  
 
 
Figure 1.12 Intraflagellar 
transport (adapted from 
Bisgrove & Yost, 2006) 
Kinesin and dynein are 
responsible for 
anterograde and 
retrograde transport along 
the axoneme respectively. 
 
A study in 2001 found that IFT52 was located on the transitional fibers, 
which are Y-shaped fibers connecting the microtubule outer doublets to the 
ciliary membrane just distal to the basal body. The transition zone, which is 
demarcated by the transition fibers, is thought not only to be a docking 
region for IFT particles but may also function as a filter controlling the 
molecular transport between cilia and cytoplasm. This speculation is based 
on evidence that the retinitis pigmentosa GTPase regulator (RPGR), a GTP 
exchange factor, appeared at the transition zone of cilia (Hong et al., 2001; 
Hong et al., 2003). 
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1.6.3 Function of cilium 
First described decades ago, primary cilia were initially considered a 
vestigial organelle with unknown physiological function. In 1985, by 
analyzing primary cilia in chondrocyte, Poole and colleagues suggested 
that primary cilia have enormous potential to function as a chemical and 
physical sensory device (Poole et al., 1985). Using chick embryo sternal 
cartilage as a tissue model, researchers discovered that primary cilia 
interacted with and were deflected by the extracellular matrix in 2001 
(Poole et al., 2001). The mechanosensor function of primary cilia was also 
reported when studying the human autosomal-recessive polycystic kidney 
disease. Abnormal short or absent of primary cilia appeared in mice with a 
mutation in the polycystic kidney disease gene, Tg737 (Pazour et al., 2000). 
Other studies demonstrate that the bending of primary cilia caused the 
increase of intracellular Ca2+ in MDCK cells and such response was 
abolished when primary cilia were removed (Praetorius and Spring, 2001; 
Praetorius and Spring, 2003). The biochemosensory function of primary 
cilia was revealed in the study of the receptor tyrosine kinase 
platelet-derived growth factor receptor alpha (PDGFRα). Schneider et al. 
demonstrated that PDGFRαα, the homodimer of PDGFRα, targeted to the 
primary cilia and responded to the specific ligand in growth-arrested 
NIH3T3 cells and primary cultured mouse embryonic fibroblasts. This 
response did not appear in fibroblasts from Tg737 mutated mice with 
disrupted formation of primary cilia (Schneider et al., 2005).  
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1.6.4 Mutations of genes encoding ciliary proteins 
Bardet-Biedl syndrome (BBS, MIM 209900) is a rare genetic disease with 
clinical features including obesity, renal malformations, polydactyly, 
congenital heart defects and diabetes (Katsanis et al., 2001). Twelve genes 
(BBS1~ BBS12) have been identified as mutated in this syndrome. Among 
these twelve, the BBS7 and BBS8 proteins are located at the base of the 
cilia. Blacque and coworkers found that the mutations of bbs7 and bbs8 
genes in C. elegans cause structural and functional defects in the cilia. 
They suggested that BBS7 and BBS8 play important, selective roles in the 
normal localization/motility of IFT particle components (Blacque et al., 
2004). 
Oro-facial-digital type 1 syndrome (MIM 311200) is a human developmental 
disorder characterized by craniofacial and digital abnormalities. Polydactyly 
in the limbs of Ofd1∆4-5/+ newborn females indicates that oral-facial-digital 
type 1 (OFD1) protein might be involved in the Shh signaling pathway 
(Ferrante et al., 2006). OFD1 is associated with IFT machinery (motors and 
IFT particles), and is essential for the formation of primary cilia (Ferrante et 
al., 2006). 
Nephronophthisis (NPHP) encompasses a polygenic group of autosomal 
recessive cystic kidney diseases in children and young adults. Previous 
studies link mutations in six NPHP genes (NPHP1 - NPHP6) to NPHP 
(Hildebrandt et al., 1997; Mollet et al., 2002; Olbrich et al., 2003; Otto et al., 
2002; Otto et al., 2003; Otto et al., 2005; Sayer et al., 2006). Moreover, 
NPHP proteins contain multiple protein-protein interaction domains and 
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appear to function as a complex in the primary cilia/basal body/centrosome 
apparatus (Olbrich et al., 2003; Otto et al., 2003; Otto et al., 2005). 
Although C. elegans with mutated nph-4 show no structural defects in cilia, 
their abnormal cilia-mediated sensory functions indicate that these proteins 
play a role in ciliary signaling (Winkelbauer et al., 2005; Wolf et al., 2005). 
1.7 Summary of previous studies on Evc 
Previous research on this topic demonstrates that mouse EVC is expressed at 
bone growth plates using β-gal as the reporter of Evc protein. The heart 
development defects appearing in 60% of the EvC patients demonstrate the 
importance of EVC protein in heart development. However, this study does not 
investigate whether Evc-/- mouse develops the heart defects appearing in EvC 
patients or the expression of Evc in developmental heart. The investigation of 
Evc in developmental heart reveals the pathomechanism of Evc in heart 
defects. 
Subcellular studies demonstrate that Evc is expressed around the basal body 
of the cilia, which are important structures in Hh signaling. The relationships 
between Evc, the cilia, and the Hh signal remain unclear. Previous studies 
demonstrate that mutant ciliary proteins may cause abnormalities in the ciliary 
structure that lead to Hh signaling defects. Since the Ihh signal was perturbed 
in Evc-/- mice and Evc protein was localized to the region around the basal 
body, this study examines the cilia structure in the absence of the Evc protein. 
Although results strongly suggest the involvement of Evc in the Hh signaling 
pathway, the exact function of the Evc protein remains unknown.  
Yeast two-hybrid analysis shows some plausible Evc interacting proteins, 
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including Evc2, Snx 5, and Snx 6 (Dr. S Tompson, personal communication). 
Although co-immunoprecipitation and co-localization studies confirm the 
interaction between Evc and Evc2 proteins, this study does not analyze the 
importance of the interaction of these two proteins. Confirming the interaction 
of Evc with Snx5 and Snx6 is a major priority for future research.  
1.8 Aims 
The main purposes of this study as follows. 
− To analyze heart development in Evc-/- mice (Chapter 3). 
− To characterize Evc expression in developmental heart in mice 
(Chapter 3). 
− To determine the precise localization of Evc protein in cells (Chapter 4). 
− To document the ciliary structure of Evc-/- cells (Chapter 4). 
− To document the subcellular distribution of the potential Evc interacting 
proteins in Evc-/- cells (Chapter 4). 
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Chapter 2 Materials and methods 
2.1 Mice 
Evc-/- mice were generated by an inframe fusion of the β-galactosidase (β-gal) 
gene (lacZ) to the first amino acid of Evc and ablated gene function by deleting 
the remaining downstream Evc exon 1 sequence as previously described 
(Ruiz-Perez et al., 2007). Mice carried the C57Bl/6J X 129Sv mixed genetic 
background. Vangl2+/- mice were kindly provided by Dr. Deborah Henderson. 
Noon of the day the vaginal plug appeared was considered as E0.5 when 
estimating the embryonic stage.  
All mouse strain maintenance and experimental procedures were performed at 
the Functional Genetics Unit (FGU) of the Institute of Human Genetics, 
Newcastle University, UK in compliance with the regulations of the Animal 
Procedures Committee, Home Office, UK, and relevant local regulations.  
2.2 Antibodies 
Table 2.1 and 2.2 list the primary and secondary antibodies used in this study. 
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Table 2.1: Primary antibodies used in this study 
Specificity Host Source Clone 
Immuno- 
fluorescen
ce stain 
Western 
blot 
α-tubulin Mouse Sigma B-5-1-2 - 1:10,000 
γ-tubulin Mouse Sigma GTU-88 1:400 1:400 
Acetyl-tubulin Mouse Sigma 6-11B-1 1:1,000 - 
Actin Rabbit Sigma Polyclonal - 1:2,000 
c-Jun Rabbit Cell Signaling 60A8 - 1:1,000 
EVC (Human)# Sheep Self produced 
(S42B) 
Polyclonal - - 
Evc (Mouse)* Sheep Self produced 
(S43B) 
Polyclonal 1:400 1:400 
Evc2 (Mouse) Goat Santa Cruz Polyclonal 1:200 1:200 
Snx5 Rabbit Santa Cruz Polyclonal - 1:1,000 
Snx6 Goat Santa Cruz Polyclonal - 1:1,000 
SuFu (Human) Goat Santa Cruz Polyclonal 1:50 - 
#Epitope: aa235-Stop (Genebank: NP_714928) (Ruiz-Perez et al., 2007) 
*Epitope: aa459-999 (Genebank: NP_067267) (Ruiz-Perez et al., 2007) 
 
Table 2.2: Secondary antibodies used in this study 
Specificity Host Source Conjugation IF Western 
blot 
Goat IgG Donkey Molecular Probe FITC 1:200 - 
Goat IgG Donkey Santa Cruz HRP  1:2,000 
Mouse IgG Rabbit Jackson 
ImmunoRearch 
Laboratories 
AMCA 1:400 - 
Mouse IgG Goat Sigma FITC 1:200 - 
Mouse IgG Goat Pierce HRP - 1:4,000 
Mouse IgG Horse Vector Laboratories Texas Red 1:200 - 
Rabbit IgG Goat Jackson 
ImmunoRearch 
Laboratories 
HRP - 1:20,000 
Sheep IgG Donkey Molecular Probes AlexaFluor 594 1:400 - 
Sheep IgG Donkey DAKO HRP - 1:1,000 
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2.3 Genomic DNA extraction 
Ear punch biopsies (2 mm diameter hole punch) were taken from 21-30 day 
old mice. Wiping the ear punch with 100% ethanol prevented cross 
contamination between animals. For DNA extraction, ear clippings from mice, 
tails from mouse embryos and MEFs were heated in 100µl of 25mM NaOH 
and 0.2mM EDTA at 95oC for 20 minutes. The solution was then neutralized 
with 100µl of 40mM Tris-HCl (pH5.0). After vortexing, samples were used 
directly or stored at -20 oC for further processing. 
2.4 Genotyping 
2.3.1 Evc genotyping 
For Evc genotyping, both LacZ and Evc exon 1 PCR products were 
amplified simultaneously. Amplification (10µl) was performed in the 
presence of genomic DNA, 1X PCR buffer (with MgSO4) (Promega), 20µM 
dNTP (Roche), 0.25µM of each primer and 0.5U Taq DNA Polymerase 
(Promega) in a tube overlayed with mineral oil. Normal PCR cycles were 1 
cycle of 94 oC, 4 minutes; 30 cycles of 94 oC, 30 seconds; 60 oC, 1 minute; 
72 oC, 1 minute and 1 cycle of 72 oC, 10 minutes in a thermal cycler 
(Thermo).  
Ten microliters of PCR product were mixed with 2µl of 6X loading dye (New 
England BioLabs Inc.) and subjected to electrophoresis on 2% agarose gel, 
containing 0.5µg/ml ethidium bromide in 1X TAE buffer at 100V for 50 
minutes. A quick-Load 100bp DNA ladder (New England BioLabs Inc.) was 
used as the molecular weight marker. The gels were then scanned by a 
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Gene Genius Bio-Imaging System (Syngene, Synoptics Ltd) with 
GeneSnap version 7.04 software.  
Evc exon 1 was amplified by primer set 
5’-CGGCGGGATGCGGCGGGTCAC-3’and 
5’-GCGCGACAGCCAAGCCACAAG-3’, which produced a 170bp fragment 
in DNA isolated from the wild type and Evc+/- mice. The 475bp lacZ gene 
fragment was amplified by primer set 5’-GCGACTTCCAGTTCAACATC-3’ 
and 5’-GATGAGTTTGGACAAACCAC-3’ from DNA samples extracted 
from Evc+/- and Evc-/- mice. 
2.3.2 Vangl2 genotyping 
Vangl2 genotyping was based on direct sequencing. Primers were 
designed with Primer3 (Rozen and Skaletsky, 2000) and synthesized by 
MWG-Biotech (Ebersberg, Germany). The Vangl2 exon8 containing the 
G>A transition mutation at position 1391 was amplified by primer set 
5’-GAATGAGCATAGAAACACCCTAGC-3’ and 
5’-AAACAAGAGCAAGAGGAAGTAGGA-3’. Amplification (20µl) was 
performed in the presence of genomic DNA, 1X PCR buffer (with MgSO4) 
(Promega), 200µM dNTP (Roche), 1µM of each primer and 2.5U Taq DNA 
Polymerase (Promega) in a tube overlaid with mineral oil. Normal PCR 
cycles were 1 cycle of 94oC, 4 minutes; 30 cycles of 94oC, 1 minute; 55oC, 
1 minute; 72oC, 1 minute and 1 cycle of 72oC for 10 minutes in a thermal 
cycler (Thermo).  
For purification, 1µl Exonuclease (NEB) and 1µl Shrimp Alkaline 
Phosphatase (USB) were added to 5µl of PCR product and the mixture was 
43 
 
incubated at 37oC for 20 minutes then at 80oC for 20 minutes. Sequencing 
reactions were performed with the same primer set using the Dye 
Terminator Cycle Sequencing Kit for MegaBACE DNA Analysis System 
(Amersham Biosciences). The sequencing reaction program was 1 cycle of 
95oC, 1 minute and 20 seconds; 30 cycles of 95oC, 30 seconds; 55oC, 15 
seconds and 1 cycle of 60oC, 1 minute in a thermal cycler (Thermo). 
To precipitate the reaction product, 80µl of 80% isopropanol (BDH) was 
added to 20µl of the reaction product and incubated in the dark for 15 
minutes. The mixture was centrifuged at 3000rcf for 30 minutes and the 
supernatant was discarded. An inverted spin at 700rcf for 30 seconds was 
performed to remove any remaining isopropanol. The sample palette was 
air dried and resuspended in a 10µl MegaBACE loading solution 
(Amersham Biosciences). MegaBACE, by IHG Sequencing Service, was 
used to analyze the sequencing products. Chromas Lite Version 2.01 
(Technelysium) was used to analyze the sequencing data 
2.5 Histological analysis 
2.5.1 Preparation of samples 
E13.5 and E14.5 embryos were dissected in PBS. The embryos were then 
fixed in 4% paraformaldehyde (PFA, Sigma) in PBS at 4 oC for 20 minutes. 
A Shandon Pathcentre Tissue Processor (Thermo Electron Corporation) 
performed the embedding procedures. The embryos were dehydrated in 
70% ethanol for 30 minutes, in 95% ethanol for 1 hour, in 100% ethanol for 
105 minutes, and in 100% ethanol for 2 hours. Tissues were then cleared 
by incubation in 100% xylene for 105 minutes and two changes of 100% 
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xylene for 2 hours. Specimens were further washed in two changes of 
paraffin wax at 60 oC for 105 minutes and two changes of paraffin wax at 60 
oC for 2 hours. Specimens were then embedded in cooling paraffin wax.  
Samples were sectioned (7µm thickness) by the microtome. The sections 
were then placed on water-covered slides. After removing superfluous 
water, the samples were placed into a 37 oC incubator for two days to 
ensure that sections were entirely dried out and firmly fixed on the slides. 
2.5.2 Hematoxylin and Eosin staining 
Immersion in two changes of a histological clearing reagent (Histo-clear) 
for 5 minutes removed the paraffin wax from the sections. Sections were 
rehydrated in serial concentrations of ethanol (100%, 75%, and 50%) for 5 
minutes. After rinsing with ddH2O, the sections were stained in Harris 
haematoxylin solution (Raymond A Limb) for 20 seconds and then washed 
in running water for 45 seconds to allow the stain to develop. The samples 
were rinsed in ddH2O followed by staining in 1% Eosin (Raymond A Limb) 
for 30 seconds. After rinsing in ddH2O, the samples were immersed in 
serial concentrations of ethanol (50%, 75%, and 100%) for 3 seconds. After 
clearing in a histological clearing reagent, the slides were mounted in 
histomount solution (Vector Laboratories). An Axioplan 2 imaging/AxioCam 
HRc microscope (Zeiss) was used to observe the slides. Photographs were 
processed with AxioVision Release 4.5 (Zeiss). 
The basic dye, hematoxylin, produced a blue-purple stain on the basophilic 
structures, such as the nucleus and the RNA-rich cytoplasmatic regions, 
whereas eosin produced a bright pink stain on eosinophilic structures, 
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composed of intracellular or extracellular protein.  
2.5 X-Gal staining 
2.5.1 Whole-mount X-Gal staining 
E11.5 and E12.5 embryos were dissected in PBS (pH7.3) and fixed in 
freshly prepared X-gal fixation solution containing 1% formaldehyde 
(Sigma), 0.2% glutaraldehyde (Sigma), 5mM EGTA (pH7.3, Sigma), 2mM 
MgCl2 and 0.02% NP40 in PBS at 4oC for 1 hour. The samples were 
washed three times in 0.02% NP40 in PBS at room temperature for 30 
minutes. X-gal reaction was performed in X-gal substrate solution 
containing 5mM K3Fe(CN)6 (Sigma), 5mM K4Fe(CN)6 (Sigma), 5mM EGTA 
(pH7.3), 2mM MgCl2, 0.02% NP40, 0.01% Na Deoxy Cholate, and 1mg/ml 
X-Gal overnight at 37 oC.  
2.5.2 Preparation of sections 
After the X-gal reaction, the samples were manually embedded in paraffin 
wax to prevent damage to the tissues. Embedding procedures were similar 
to that of the Shandon Pathcentre Tissue Processor (Thermo Electron 
Corporation) (Section 2.5.1) with a slightly different solution and incubation 
period. The embryos were dehydrated in 50% ethanol for 1 hour (once), in 
70% ethanol for 1 hour (twice), in 95% ethanol for 1 hour (once) and in 
100% ethanol for 1 hour (twice). Tissues were then cleared by incubation in 
two changes of histological clearing reagent for 20 minutes and histological 
clearing reagent/wax (1:1) at 65 oC for 20 minutes. Specimens were further 
washed in three changes of paraffin wax at 65 oC for 40 minutes and then 
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embedded in cooling paraffin wax.  
Sections (14µm thickness) were prepared by a microtome and firmly 
attached to the slides as previously described (Section 2.5.1). Samples 
were twice immersed in histological clearing reagent for 5 minutes to 
remove the wax and then immersed for 5 minutes in each serial 
concentration of ethanol (100%, 75%, and 50%) to rehydrate them. After 
rinsing with ddH2O, the samples were stained in nuclear fast red solution 
for 2 minutes and rinsed in ddH2O. Then, the samples were immersed in 
serial concentrations of ethanol (50%, 75%, and 100%) for 3 seconds and 
a histological clearing reagent for 3 minutes. Slides were mounted in 
histomount solution and observed with an Axioplan 2 imaging/AxioCam 
HRc microscope. Photographs were processed with AxioVision Release 
4.5. 
2.7 In situ hybridization 
2.7.1 Probes preparation 
The plasmids containing Shh, Ptc, and Evc cDNA were kindly provided by 
Dr. M. Nakatomi. The details of probes were listed in Table2.3. For 
linearization, 30µg of plasmid was incubated overnight in 200µl of a 
relevant restriction enzyme and restriction buffer (HindIII for Shh, BglII for 
Ptc, and NotI for Evc) at 37 oC. 200µl ddH2O with vortex and 400µl 
phenol/chloroform/isoamyl alcohol (25:24:1) (Sigma) with vortex were then 
added. After centrifuging at 12000rcf at 4 oC for 5 minutes, 380µl of the 
resulting supernatant was transferred into a new tube and mixed with an 
equal volume of chloroform. This mixture was then centrifuged at 12000rcf 
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at 4 oC for 5 minutes, after which, 350µl of supernatant was transferred into 
a new tube and mixed with 35µl of vortexed 3M NaOAc. 1ml 100% ethanol 
was added and the solution gently mixed prior to incubating at -80 oC for 1 
hour. After centrifuging at 13000rcf at 4 oC for 20 minutes, the pellet was 
washed with 1ml of 70% vortexed ethanol. This was then centrifuged 
at13000rcf at 4 oC for 3 minutes, the supernatant was discarded, and the 
pellet was air-dried. Next, the pellet was suspended in a 20µl TE buffer and 
the concentration was measured. A transcription reaction was performed at 
37 oC for 3 hours in 20µl total volume containing 1µg DNA, 2µl 10X buffer 
(Roche), 2µl Dig Mix (Roche), 1µl RNase inhibitor (Promega) and 2µl 
relevant polymerase (Roche; T3 for Shh, T7 for Ptc, and Sp6 for Evc). The 
products were mixed with 80µl TE buffer, 10µl 4M LiCl, and 250µl 100% 
ethanol gently shaken and incubated at -20°C overni ght. After centrifuging 
at 13000rcf at 4 oC for 20 minutes, the supernatant was discarded and the 
pellet was air dried and suspended with 100µl TE buffer. 
 
Table 2.3 Detail of probes used in this study 
Probe Targeting Gene Size (bp) Location of Probe 
Evc 792 bp 926-1717 (NM_021292) 
Shh 643 bp 20-762 (NM_009170) 
Ptc 4.3 kb Full length (NM_008957) 
 
2.7.2 Hybridization 
The sections were deparaffinized two times in xylene for 5 minutes, two 
times in 100% ethanol for 5 minutes, two times in 70% ethanol for 5 
minutes, and two times in PBS (pH7.4) for 10 minutes. After 
deparaffinization, the sections were treated with 200µg/ml of ProteaseK for 
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10 minutes and 2mg/ml of glycine for 10 minutes. The sections were then 
washed in PBS (pH7.4) for 5 minutes and fixed in 4% PFA in PBS (pH7.4) 
for 20 minutes. After washing in PBS (pH 7.4) three times for 5 minutes, the 
sections were immersed in water that was continually stirred for 10 minutes. 
This water contained 1.325% (v/v) triethanolamine, 0.175% (v/v) HCl, and 
0.25% (v/v) acetic anhydrate, which was injected into the water at the rate 
of 100µl/15sec. The sections were washed in PBS (pH 7.4) three times for 
5 minutes and then incubated with a hybridization buffer containing 50% 
formamide, 10mM Tris-HCl pH 7.6, 100µg/ml yeast tRNA, 1X Denhardt’s 
solution, 5% Dextran sulphate, 600mM NaCl, 0.25% SDS, and 1mM EDTA 
pH 8.0 for 1hour. Probes were mixed with the hybridization buffer and 
denatured at 80oC for 10 minutes. After applying the probes, the sections 
were covered with paraffin to avoid drying during incubation. The 
incubation chamber was kept humid by placing inside the chamber a 30ml 
solution containing 50% formamide, and 2X SSC. The whole chamber was 
covered by cling film. The sections were incubated overnight with probes at 
70 oC. After incubation, the paraffin was removed with 5X SSC pH7.0 at 70 
oC . The sections were washed in 2X SSC pH7.0 at 70 oC for 1 hour, all the 
while being gently shaken. After washing for 5 minutes with TBS containing 
10mM Tris-HCl pH7.6 and 150mM NaCl, the sections were incubated with 
a blocking solution containing 100mg of blocking reagent/10ml TBS for 1 
hour. The sections were then incubated overnight with the anti-Dig 
antibody (1µl/5ml TBS) at 4 oC. Next, the sections were washed in TBS 
three times for 5 minutes and, then, washed for 5 minutes in NTM solution 
containing 100mM Tris-HCl pH9.6, 100mM NaCl, and 5mM MgCl2. A 
reacting solution containing 9% polyvinylalcohol, 90mM NaCl, 100mM 
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Tris-HCl pH9.6, 5mM MgCl2, and 0.5% (v/v) NBT/BCIP solution was 
applied to the sections to start color development. To stop the reaction, the 
sections were rinsed with TBS, immersed in PBS for 5 minutes, and 
covered by cover glass with a mounting medium. 
2.8 Cell culture 
All cells were grown in a humidified atmosphere with 5% CO2 at 37 oC. 
2.8.1 Murine inner medullary collecting duct cells (mIMCD-3) 
mIMCD-3 cells originally obtained from ATCC (Cat: CRL-2123TM) were 
kindly provided by Dr. L. Eley. mIMCD-3 were grown in DMEM/F-12 (v/v = 
1:1) supplemented with 10% fetal bovine serum (FBS) and 10% 
non-essential amino acids. In the case of purmorphamine treatment, cells 
were grown in a medium with 2µM of purmorphamine for 72 hours. 
2.8.2 Mouse embryonic fibroblasts (MEFs) 
Mouse embryonic fibroblasts were kindly generated from Evc-/- and wild 
type mice by Dr. H. Blair. MEFs were grown in DMEM supplemented with 
10% FBS, 10% non-essential amino acids, and 5% penicillin/streptomycin. 
To induce cilia formation, cells were cultured in a serum free medium for 
16-20 hours following the experiment. 
2.8.3 Primary culture of osteoblasts and chondrocytes 
The tibial cartilage and calvarial bone were dissected from mouse embryos 
at E18.5 and placed into a PBS containing 2% penicillin/streptomycin and 
1% ampateracin. Then the tissues were treated with a 0.1% hyaluronidase 
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solution for 5 minutes, a 0.25% trypsin solution for 10min and a 0.3% 
collagenase solution for 4 hours. All solutions were prepared freshly and 
the treatments were performed with gentle rotation at 37 oC. The solution 
with the cells was centrifuged at 5,000rcf for 5 minutes. After discarding the 
supernatant, the pellets were resuspended in a medium containing 25mM 
HEPES, 10% FCS, 1% L-glutamine, 2% penicillin/streptomycin, 1% 
fungizone, and 1% non-essential amino acids and then plated on an 8-well 
chamber slide (Nunc) or Culture Inserts (Nunc). For cilia generation, cells 
were cultured in a serum free medium for 16-20 hours. 
2.9 Deciliation 
After washing with PBS, the cells were treated with 15.7mM Tris-HCl (pH7.5), 
79.1mM NaCl, 1.56mM EDTA, 0.1% Triton X-100, 30mM CaCl2, 1X protease 
inhibitor (Roche) and 0.5mM phenylmethanesulphonylfluoride (Roche) for 5 
minutes at room temperature to remove the cilia (Fliegauf et al., 2006). After 
collecting the solution, the cells were then washed with PBS and were ready 
for the Immunofluorescence staining. The collected solution was centrifuged at 
16,000rcf for 10 minutes at 4 oC. The supernatant was discarded and the 
pellets were resuspended in 3µl PBS and spotted onto a charged slide 
(Menzel-Gläser). After drying at 37 oC, the slide was finally ready for 
Immunofluorescence staining. 
2.10 Immunofluorescence staining 
A serum free growth medium induced cilia formation in cells cultured on a slide 
flask. Cells before and after deciliation treatment as well as the deciliated cilia 
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were collected and fixed in 4% PFA in PBS for 20 minutes at 4oC and then 
washed three times for 5 minutes in PBS. The samples were treated with 0.1% 
Triton X-100 in PBS for 10 minutes at room temperature then washed twice for 
5 minutes with PBS. After treating with PBST (0.1% Tween 20 in PBS) for 5 
minutes at room temperature, the samples were incubated in 10% normal 
horse serum (Vector Laboratories) in PBST for 1 hour at room temperature. 
The samples were then incubated with the primary antibody (Table 2.1) and 
diluted in PBST containing 10% normal horse serum for 2 hours at room 
temperature. After washing three times for 10 minutes in PBST, the samples 
were exposed to the secondary antibody (Table 2.2) for 45 minutes at room 
temperature. The samples were then washed three times for 10 minutes in 
PBST and then mounted with a mounting medium containing 
4’-6-diamidino-2-phenylindole (DAPI) (Vector Laboratories). When the AMCA 
conjugated secondary antibody was applied in staining, samples were 
mounted with a mounting medium without DAPI (Vector Laboratories). The 
samples were observed with an Axioplan 2 imaging/AxioCam HRm 
microscope (Zeiss). Photographs were processed with AxioVision Release 
4.5. 
2.11 Transmission electron microscope 
2.11.1 Ciliary structure examination 
Cells cultured in Culture Inserts (Nunc) were fixed with freshly prepared 2% 
PFA in PBS for 1 hour at 4 oC. After washing with PBS, the membrane with 
the cells on it was cut into strips and rinsed in a 0.1M phosphate buffer 
three times for 15min. The samples were treated with 70% ethanol for 1 
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hour, 50% ethanol in LRwhite resin for 1 hour and in LRwhite resin alone 
for 1 hour (twice), after which, samples were embedded overnight in 
LRwhite resin at 50 oC. Ultra thin sections (~80nm) on nickel grids were 
prepared by the EM unit service of the University of Newcastle upon Tyne. 
2.11.2 Immuno-TEM 
Standard staining procedures are described below. The sections were 
incubated in 80mM ammonium chloride in PBS for 10 minutes followed by 
two incubations in 0.5% BSA/Glycine in PBS for 5 minutes. After incubation 
with 10% rat serum/0.5% BSA in PBS for 30 minutes, sections were 
washed in 0.5% BSA in PBS three times for 5 minutes each time. Sections 
were then incubated overnight with the primary antibody (Table 2.1) or the 
antibody-free control at 4 oC. After washing in 0.5% BSA in PBS three times 
for 5 minutes each time, the sections were incubated at room temperature 
for 1 hour or overnight at 4 oC with the gold conjugated secondary antibody 
(Table 2.2) in 0.5% BSA in PBS which was pre-incubated with normal 
horse serum (antibody/serum: 2/1) for 1 hour at room temperature. The 
sections were then washed six times in 0.5% BSA in PBS for 5 minutes and 
4 times in distilled water for 5 minutes. After incubating in 2% aqueous 
uranyl acetate for 20 minutes, the sections were rinsed in distilled water by 
dipping them 5 times in water that was changed with each dip. They were 
then dried with filter paper and were ready for observation with a TEM. 
In the case of pre-section staining, cells grown in culture inserts were 
treated and stained with the S43B antibody following the procedures for 
Immunofluorescence staining described in section 2.10. After incubation 
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with S43B, the samples were washed with PBST three times for 5 minutes 
and sent to the EM unit in Newcastle University for the embedding and 
sectioning procedure. Staining steps followed the standard staining 
procedures but omitted the primary antibody incubation.  
In the case of post-section staining, cells grown in culture inserts were fixed 
in 4%PFA in PBS at 4 oC for 20 minutes, after draining the growth medium. 
They were then washed in PBS three times for 5 minutes each time. Next, 
the cells were penetrated with 0.1% Triton/PBS for 10 minutes then 
washed twice for 5 minutes in PBS and 5 minutes in PBST. After these 
treatments, the samples were sent to the EM unit in Newcastle University 
for the embedding and sectioning procedure. Staining steps followed 
standard staining procedures and three different dilution concentrations 
(1/100, 1/400 and 1/1,000) of primary antibody were applied to the 
sections.  
In the case of the detergent-free staining, cells grown in culture inserts 
were fixed in freshly prepared 2%PFA in PBS at 4 oC and left overnight 
after draining the growth medium. After three, separate, 5-minute washings 
with a phosphated buffer, samples were sent to the EM unit in Newcastle 
University for the embedding and sectioning procedure. Staining steps 
followed standard staining procedures and three different dilution 
concentrations (1/100, 1/400 and 1/1,000) of the primary antibody were 
applied to the sections. 
2.12 Subcellular fractionation 
Subcellular fractionation was performed following previously published 
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methods (Becker et al., 1995). Both wildtype and Evc-/- MEFs from two T75 
flasks were harvested with trypsin after serum starvation for 20 hours. After 
washing with ice cold PBS and centrifuging at 1,000rcf for 5 minutes at 4 oC, 
pellets were resuspended in ice cold PBS and transferred into eppendorfs. 
Cells were centrifuged at 6,000rcf for 2 minutes at 4 oC and the pellets were 
resuspended in 50µl of lysis buffer A containing 10mM HEPES pH7.9, 10mM 
KCl, 0.1mM EDTA, 0.1mM EGTA, 2mM DTT (freshly added) and a Protease 
Inhibitor (Roche, freshly added, 1 tablet in 10ml lysis buffer A). The 
resuspended cells were placed on ice for 15 minutes and an additional 2 
minutes after adding 33µl 10% NP40. After centrifuging at 12,000rcf for 30 
seconds at 4 oC, the supernatants were collected as cytoplasmic fraction 1 
(C1). To ensure that the fraction worked efficiently, the pellets were 
resuspended in 50µl of lysis buffer A and centrifuged at 12,000rcf for 30 
seconds at 4 oC. This step was repeated five times to obtain the fractions 
C2-C7. The pellets after fraction C7 were resuspended in 30µl of lysis buffer B 
containing 20mM HEPES pH7.9, 0.4mM NaCl, 1mM EDTA, 1mM EGTA, 2mM 
DTT (freshly added) and Protease Inhibitor (Roche, freshly added, 1 tablet in 
10ml lysis buffer B) and incubated on ice for 1 hour with a strong vortex at 10 
minutes intervals. After centrifuging at 12,000rcf for 5 minutes at 4 oC, the 
supernatant was collected as the nuclear fraction (N). 
2.13 Western blotting 
2.13.1 Preparation of protein samples 
The MEFs from two T75 flasks were scrubbed with ice-cold PBS and 
centrifuged at 1,000rcf for 5 minutes at 4 oC. The subsequent pellets were 
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washed by resuspension and by centrifuging twice with ice-cold PBS. A 2X 
loading buffer was used to resuspend the pellet thoroughly and the 
samples were stored at –80 oC. The samples were heated at 95 oC before 
loading. 
The subcellular fractionation, fractions (C1 ~ C7 and N) stored at –80 oC, 
were thawed on ice and then mixed with equal volumes of the 2X loading 
buffer for total volume 10µl. The samples were heated at 95 oC before 
loading. 
2.13.2 Eletrophoresis and transfer 
Samples were loaded into 7.5% Tris-HCl Ready-Gel (Bio-Rad Laboratories) 
or 4-12% Bis-Tris NuPAGE® gel (Invitrogen Corporation). In Tris-HCl 
Ready-Gel, the running buffer contains 1.5g/l Tris-base, 7.2g/l glycine, and 
0.5% SDS. In Bis-Tris NuPAGE® gel, the electrophoresis system followed 
the manufacturer’s instructions and contained the MES SDS-Running 
Buffer (Invitrogen Corporation) and NuPAGE® Sample Reducing Agent 
(Invitrogen Corporation). In both systems, the 5µl Rainbow marker was 
used as the protein marker and the electrophoresis was performed at 200V 
for 1 hour. 
Protein transfer was performed with the Western blot transfer system 
(Bio-Rad Laboratories). For one hour, the protein samples were transferred 
to the transfer membranes (Hybond-C extra, GE Healthcare Bio-Sciences) 
with a transfer buffer containing 25mM Tris-base, 0.2M glycine and 20% 
methanol at 350mA. After washing twice in Tris-buffered saline Tween-20 
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(TBST) containing 50mM Tris (pH7.5), 150mM NaCl and 0.05% Tween 20, 
the membrane was stored in TBST at 4 oC. 
2.13.3 Antibody staining 
After blocking in 5% skimmed milk in TBST at room temperature for 1 hour 
or overnight at 4 oC, the membrane was incubated with primary antibodies 
diluted in 5% skimmed milk in TBST for 1 hour. After washing three times 
for 10 minutes each time in TBST, the membrane was incubated in a 
HRP-conjugated secondary antibody diluted in 5% skimmed milk in TBST. 
The unbounded secondary antibody was removed by three, separate, 
10-minute washes in TBST. The ECL Regent (GE Healthcare) was used as 
the substrate for the HRP enzyme producing chemiluminescence, which 
could be detected with X-ray film (Kodak) and developed using an 
automatic X-ray film processor (Xograph Healthcare Ltd.).  
The commercial goat anti-Evc antibody, obtained from Santa Cruz, was 
verified by pre-incubation with a blocking peptide (Santa Cruz) the 
sequence of which was not available. 
2.14 Statistical analysis 
Fisher’s exact test was used to analyze whether the abnormalities observed in 
Evc-/- were significantly difference from the wild type. Fisher’s exact test is a 
statistical test widely used to analyze contingency tables where sample sizes 
are small (Fisher, 1922).  
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Chapter 3: The role of Evc in heart development 
3.1 Introduction 
3.1.1 Cardiovascular malformation in EvC syndrome 
EvC syndrome is an autosomal recessive disease characterized by short 
ribs, short limbs, postaxial polydactyly, fingernail dystrophy, multiple oral 
frenula, neonatal teeth, delayed tooth eruption, and cardiac defects 
(Biggerstaff and Mazaheri, 1968; Ellis and Van Creveld, 1940; McKusick et 
al., 1964; Taylor et al., 1984). Approximately 60% of affected individuals 
suffer from cardiac defects, which are the major reasons for early death in 
EvC syndrome. The most frequent cardiac abnormalities in human patients 
are defects in atrioventricular septation and a single atrium (Digilio et al., 
1999; Katsouras et al., 2003). Although research has detected low levels of 
EVC expression at Carnegie stages 19 and 21 in developing bone, heart, 
kidney, and lung in human embryos (Ruiz-Perez et al., 2000), the functions 
of EVC in developing heart and the pathomechanism of cardiovascular 
malformation in the absence of EVC protein are poorly understood. 
3.1.2 Evc knockout mice 
Evc-/- mice were generated through replacing Evc exon 1 with a 
β-galactosidase gene in an in-frame status in our group. The RT-PCR study 
confirmed the absence of Evc transcripts in Evc-/- mice (Ruiz-Perez et al., 
2007). Similar to human patients, Evc-/- mice have short ribs, short limbs, 
and dental abnormalities. The above study did not observe polydactyly in 
Evc knockout mice (Ruiz-Perez et al., 2007), and had not studied 
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histological changes of the heart in Evc-/- mice at the beginning of the study. 
3.1.3 Aims 
This chapter focuses on analyzing the heart development in Evc-/- mice 
and the expression of Evc in mouse heart development. 
3.2 Histological analysis of Evc-/- heart 
This section, if not specified, places the dorsal side of embryo 
sections toward the top of the page, while the right side of 
embryo sections are placed toward the left side of the page. 
LA: left atrium; LV: left ventricle; PAS: primary atrial septum; 
RA: right atrium; RV: right ventricle 
 
3.2.1 Genotype analysis 
To understand the function of Evc in heart development, this study used 
Evc-/- mice. Genotyping the embryos from Evc+/- x Evc+/- parents (section 
2.4) was undertaken on genomic DNA extracted from embryo tails or from 
MEFs (to check cell lines) amplified with primer sets specific to exon 1 of 
Evc and LacZ simultaneously (Ruiz-Perez et al., 2007). The PCR products 
were separated by electrophoresis through 2% agarose. In the wild type 
mice, only Evc exon 1 was amplified, giving a single band of 180bp on gel. 
The samples from homozygous Evc-/- mice showed the single LacZ band of 
450bp on gel whereas Evc exon 1 and lacZ fragments were amplified and 
180bp and 450bp bands were observed in the agrose gel. The 
representative photos in figure 3.1 demonstrate that PCR is a rapid and 
Dorsal 
Left 
Ventral 
Right 
 clear method to identify embryo genotypes.
 
 
 
 
 
LacZ  
 
Evc exon1 
Figure 3.1 Electrophoresis analyses of PCR products for 
genotyping. 
Simultaneously amplified PCR products of 
analyzed by 2% agarose electrophoresis. M: 100bp DNA ladder (NEB); B: 
PCR blank 
 
3.2.2 Characterization
Histological analysis 
embryonic stages (E14.5, E15.5, and E18.5) and newborn mice were 
performed. The samples were sectioned and stained with H&E followed by 
histological analysis. Twenty
used in this study, 23 embryos at different developmental stages, and 2 
newborn mice (Table 3.1). 
 
Table 3.1 Numbers of mice offspring analyzed at each developmental 
stage 
 Wild type
E14.5 2 
E15.5 0 
E18.5 3 
Newborn 1 
Total 6 
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 M Evc-/- Evc+/- Evc+/+ 
LacZ and exon1 of 
 of heart development in Evc-/- mice
(section 2.5) of the thorax region of mice at different 
-five offspring of Evc+/- × Evc+/- crosses were 
 
 Heterozygous Homozygous 
4 8 
1 1 
0 4 
0 1 
5 14 
B  
 
Evc 
Evc were 
 
Total 
14 
2 
7 
2 
25 
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Six litters were harvested and embedded in paraffin wax. The chest area 
was sectioned into 7µm thickness and H&E stained. To obtain the insight of 
Evc protein in heart development, sections from different areas of the heart 
were closely analyzed. 
Among eight different litters collected (Table 3.2), no significant difference 
in cardiovascular variances was observed in Evc-/- mice (Table 3.3). 
Consisting with previous study in our group, the number of embryos 
observed in this study met to the estimation by Mendelian inheritance. In 
particular, no instance of common atrium or atrioventricular defects was 
observed. Several minor abnormalities were detected in the samples, 
including abnormalities of heart position, the ventricular septum muscle, the 
trabeculae, fusion of the ventricular septum with the atrioventricular 
cushion tissue, and atrioventricular valves, but these were also observed in 
wild the type and heterozygous controls. These observations are described 
below. 
 
Table 3.2 Collected embryos and mice 
Litter Number Age Evc+/+ Evc+/- Evc-/- Total 
1 E14.5 0 4 3 7 
2 E14.5 2 5 4 11 
3 E14.5 2 7 1 10 
4 E15.5 3 7 1 11 
5 E18.5 1 1 2 4 
6 E18.5 2 4 2 8 
7 E18.5 4 5 3 12 
8 P0 2 5 1 8 
Total  16 38 17 71 
 
 
 
61 
 
Table 3.3 Embryos and mice used for studying heart developmental 
defects 
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1 E14.5 Evc+/-       
2 E14.5 Evc+/-       
3 E14.5 Evc-/-   X   X 
4 E14.5 Evc-/- X X  X  X 
5 E14.5 Evc-/-  X    X 
6 E14.5 Evc+/+    X  X 
7 E14.5 Evc+/- X X  X  X 
8 E14.5 Evc+/- X X X    
9 E14.5 Evc-/-   X   X 
10 E14.5 Evc-/-    X  X 
11 E14.5 Evc-/- X X X   X 
12 E14.5 Evc+/+       
13 E14.5 Evc-/- X X     
14 E14.5 Evc-/-   X X  X 
15 E15.5 Evc+/-     X  
16 E15.5 Evc-/-       
17 E18.5 Evc+/+       
18 E18.5 Evc-/- X X     
19 E18.5 Evc-/- X X  X   
20 E18.5 Evc+/+ X X X X   
21 E18.5 Evc-/- X X  X   
22 E18.5 Evc+/+ X X X X   
23 E18.5 Evc-/- X X     
24 P0 Evc+/+ X X  X   
25 P0 Evc-/-  X X X   
  
 12 14 8 11 1 9 
 
3.2.3 Heart and ventral apex positions 
In mouse embryos, the heart is located in the middle of the chest cavity 
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with the apex inclined towards the left (You et al., 2005). Among 12 of 25 
samples analyzed, the heart was observed in the left half of the thorax 
(Figure 3.2). The right ventricle as the ventral apex typically accompanies 
an abnormal heart position. The 12 samples included 3 of 6 in the wild-type, 
2 of 5 in the heterozygous type, and 7 of 14 in the homozygous embryos. 
No statistical significance was detected in the occurrence rate of heart 
deflection and apex of heart between the wild-type/heterozygous and 
homozygous samples (Fisher’s exact test, p=1 and 0.43 respectively).  
 
 
Figure 3.2 Abnormality in the 
position of heart and ventral 
apex 
In normal mouse embryos, the 
heart is located in the middle of 
the chest. The figure shows 
deflection of heart position to the 
left side of the body in one of 
Evc+/- mice (E14.5). Bar: 500µm 
 
3.2.4 The shape of the trabeculae 
Trabeculae carnae located at the wall of the ventricle are normally pillar 
shaped (Figure 3.3, A and C). Clubbed trabeculae in the left ventricle were 
observed in 8 of 25 samples (Figure 3.3, B, and D). The eight samples 
included 2 of 6 in the wild-type, 1 of 5 in the heterozygous, and 5 of 14 in 
homozygous embryos and newborn. No statistical significant difference 
was observed in the occurrence rate of abnormality in the shape of 
trabeculae between wild-type/heterozygous and homozygous samples 
(Fisher’s exact test, p= 1). 
 
LA 
RA 
LV 
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Figure 3.3 Representative figures on abnormality in the shape of 
trabeculae 
In most mice, trabeculae are pillar shaped at the ventricle wall (A and C, 
Evc+/-, E14.5). Clubbed and bud structural trabeculae, indicated by the red 
arrow, were observed in some mice (B and D, Evc-/-, E14.5). C and D 
represent higher magnification of the red square region in A and B. Bar in A 
and B: 500µm; in C and D: 200µm. 
 
3.2.5 Ventricular septum 
The myocardial wall grows at the middle of the ventricle, forming the 
septum that eventually separates the left from the right ventricle. At E14.5, 
the ventricular septum should be well developed and fused with the AV 
cushion tissue (Figure 3.4, A and C). One E14.5 heterozygous embryo had 
RA 
RA 
LV 
LV 
RV 
RV 
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a space between the ventricular septum and the AV cushion, suggesting a 
ventricular septum defect in this embryo (Figure 3.4, B, and D). The 
analysis did not reach statistical difference even though variance was not 
observed in any of the 14 Evc-/- mice (Fisher's exact test, p=0.44). 
 
A 
 
B 
 
C 
 
D 
 
Figure 3.4 Representative figures on attenuation of ventricular 
septum 
The ventricular septum is fused with the AV cushion tissue in the E14.5 
embryo (A and C, Evc+/-, E14.5). One of five heterozygous mice showed 
impaired development of the ventricular septum. The gap between the 
ventricular septum and the AV cushion tissue is indicated by red arrows (B 
and D, Evc+/-, E15.5). C and D represent higher magnification of the red 
square region in A and B. Bar in A and B: 500µm; in C and D: 200µm 
 
RA 
RV RV 
LV LV 
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3.2.6 Structure of the ventricular septum 
The interventricular septum is typically shown as a stout wall separating the 
ventricles of the heart (Figure 3.5, A and C). However, a thinner septum 
with spaces was observed in 11 out of 25 samples, including 4 of 6 in the 
wild-type, 1 of 5 in the heterozygous type, and 6 of 14 in homozygous 
embryos and newborn (Figure 3.5, B and D).  
 
A 
 
B 
 
C 
 
D 
 
Figure 3.5 Loose structure of ventricular septum 
The ventricular septum muscle is a solid structure as shown in A and C 
(Evc+/-, E14.5). Eleven of 25 samples showed a loose structure of 
ventricular septum as indicated in red arrows in B and D (Evc-/-, E14.5). C 
and D represent higher magnification focus on the red square region in A 
and B. Bar in A and B: 500µm; in C and D: 200µm. 
 
No significant difference was observed between wild-type/heterozygous 
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RA 
LV LV 
LV LV 
RV RV 
RV 
RV 
66 
 
and homozygous mice (Fisher's exact test, p=1). 
3.2.7 AV valve structure 
AV valves are located between the atria and the ventricles. The valves 
anchor to the ventricle wall by chordae tendineae and prevent backflow 
from the ventricles into the atria during systole. AV valves are differentiated 
from the extracellular matrix and mesenchymal cells and should be flat 
leaflet structures (Figure 3.6, A and C). An unusual structure with a dilated 
bubble at the end of the leaflet was observed (Figure 3.6, B, and D). One of 
6 wild type, 1 of 5 heterozygous type, and 7 of 14 homozygous mice 
showed this phenotype. While the proportion of mice with this abnormality 
was higher in Evc-/- mice compared to the wild type and heterozygous 
littermates, this difference did not reach statistical significance (Fisher’s 
exact test, p= 0.2). 
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Figure 3.6 Unusual bubble structures at the end of AV valves  
The valves and the homogenous structure are flat, as shown in A and C 
(Evc+/-, E14.5). Red arrows indicate the bubble structure at the end of AV 
valves observed in this study (B and D, Evc+/-, E14.5). C and D represent 
higher magnification focus on the red square region in A and B. Bar in A 
and B: 500µm; in C and D: 200µm 
3.2.8 Summary 
In conclusion, no statistical differences were observed in hearts between 
the wild type/heterozygous and homozygous samples among these 
uncommon phenotypes (Table 3.4 and Figure 3.7). 
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Table 3.4 Numbers of embryos of each genotype with heart 
abnormalities 
Abnormality 
Evc+/+  
(n=6) 
Evc+/- 
(n=5) 
Evc-/- 
(n=14) p value 
Heart position 3 2 7 1 
Apex of heart 3 2 9 0.43 
Trabecula 2 1 5 1 
Fusion of ventricular septum 
with atrioventricular cushion 
tissue 
0 1 0 0.44 
Ventricular septum muscle 4 1 6 1 
Atrioventricular valves 1 1 7 0.2 
 
 
 
Figure 3.7 Occurrence rates of abnormalities in different mouse 
genotypes 
Abnormalities of atrioventricular valves demonstrated a higher frequency in 
homozygous samples compared to those in wild type or heterozygous 
samples. 
 
+/+ & +/- with normal appearance 
+/+ & +/- with abnormal appearance 
-/- with normal appearance 
-/- with abnormal appearance 
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3.2.9 Cardiac development analysis in an inbred strain 
As phenotypes are often more apparent in an inbred background than a 
mixed background, the Evc-/- mice with C57Bl/6J-129Sv genetic 
background were backcrossed with the inbred strain C57Bl/6J for nine 
generations. The mice carried 99.9% of the inbred C57BL/6J background. 
The thorax region of E14.5 inbred strain embryos was analyzed as 
previously described in three litters, twelve embryos in total. With the 
exception of the loose structure of the ventricular septum muscle, no other 
cardiac defects were observed in Evc-/- mice with inbred C57Bl/6J genetic 
background (Table 3.5; Figure 3.8). 
 
Table 3.5 Numbers of embryos of each genotype from inbred strain 
C57Bl/6J mice with uncommon heart features 
Abnormality Wild type (3) Heterozygous (4) Homozygous (5) 
Heart position 0 0 0 
Apex of heart 0 0 0 
Trabecula 0 0 0 
Ventricular septum muscle 1 1 1 
Fusion of ventricular septum 
with atrioventricular cushion 
tissue 
0 0 0 
Atrioventricular valves 0 0 0 
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Figure 3.8 Loose structure of ventricular septum observed in inbred 
strain mice 
In wild type (right panel), the solid muscular ventricular septum was 
observed in the left panel at E14.5. In one sample of each genotype from 
inbred strain mice (left panel, Evc+/-), the loose structure of ventricular 
septum was observed. Bar: 500µm 
 
The loose structure of the ventricular septum was found in the thorax 
region in one embryo of each genotype. No significant difference 
evidenced in the occurrence rate of this phenotype between the 
wild-type/heterozygous and homozygous samples.  
3.2.10 Vangl2 and Evc double knockout mouse study 
This study observed no obvious heart developmental variance in Evc-/- 
mice. Among all (~1,500) Evc mouse stock, one of the Evc+/- mice revealed 
a curly tail phenotype while the loop tail is one of the abnormalities in 
Vangl2+/- mice (Phillips et al., 2008). The Vangl2, also known as Strabismus, 
Lpp1 or Ltap, has been shown to encode a protein homologous to 
Drosophila strabismus/van gogh (vang)(Kibar et al., 2001). Mammalian 
Vangl2 and Drosophila Vang proteins contain four putative transmembrane 
domains and a PDZ-binding domain. In Drosophila, Vang is a key 
component of a frizzled/disheveled pathway, essential for regulating planar 
RA 
RA 
LV LV 
RV RV 
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cell polarity and, in some tissues, cell fate (Taylor et al., 1998; Wolff and 
Rubin, 1998). Although studies have not identified the activating ligand in 
Drosophila, the pathway is highly conserved in vertebrates where it 
appears to be activated by Wnt binding to the frizzled receptor (Taylor et al., 
1998; Wolff and Rubin, 1998). The heterozygous Vangl2 mouse shows the 
loop tail phenotype while the homozygous mouse shows the complete 
open neural tube in the hindbrain and spinal region.  
Although the expression of EVC in the heart has not been verified, atrial 
septal defects were observed in 60% of EVC deficient patients. OFT 
defects were observed in Vangl2 knockout mice. As the Shh pathway 
down-regulates in Evc-/- mice, Vangl2 is one of the members of Wnt 
signaling. Many different tissue developments have reported the crosstalk 
between Wnt and Shh signaling (Alvarez-Medina et al., 2008; Borycki et al., 
2000; Iwatsuki et al., 2007; Lei et al., 2006; Sarkar et al., 2000). These 
researches suggest that the expression of Wnt signaling compensates for 
heart developmental defects in Evc-/- mice. To investigate the heart 
development in Evc-/- mice without Wnt signaling, this study planned to 
generate Evc and Vangl2 double knockout mice. To achieve this, Evc+/- 
female and Vangl2+/- male crosses were set up for the double heterozygous 
offspring to mate. 
Since Vangl2+/- mice carry the G>A transition mutation in exon 8, all 
genomic DNA of the offspring were amplified by PCR and analyzed by 
direct sequencing (Figure 3.9).  
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Figure 3.9 Sequencing analyses of different genotypes of the Vangl2 
gene 
The transition mutation in exon 8 of the Vangl2 gene (G>A, arrow) was 
analyzed with direct sequencing. Three genotypes, the wild type (A), the 
heterozygous type (B), and the homozygous type (C), could be 
distinguished with no ambiguities. 
 
Six litters of the crosses of Evc+/- female and Vangl2+/- male were collected. 
Among 19 female offspring, only two females were Evc+/-;Vangl2+/-. When 
these two Evc+/-;Vangl2+/- females were crossed with Evc+/-;Vangl2+/- males, 
no Evc-/-; Vangl2-/- double knockout mice were obtained (Table 3.6). 
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Unfortunately, the study was not continued, due to time and cost restraints.  
 
Table 3.6 Mouse embryos obtained from Evc+/-;Vangl2+/- parents 
Vangl2 
Evc 
+/+ +/- -/- 
+/+ 1 1 1 
+/- 3 1 1 
-/- 0 1 0 
 
3.3 Analysis of Evc gene expression 
3.3.1 LacZ as in indicator of Evc protein expression 
Since the anti-Evc antibody used in our group does not work on paraffin 
sections (Dr. H. Blair, personal communication), X-gal staining (section 2.6) 
was used as the exon1 of Evc gene to replace the LacZ in Evc-/- and Evc+/- 
mice as an indicator. X-gal staining positive cells detected in wild type 
samples represents endogenous β-galactosidase activity. The blue signal 
observed only in heterozygous or homozygous embryos after X-Gal 
staining, but not in the wild type, infers the expression of Evc protein.  
As the atrial septum starts to develop from E10.5 to E13.5 in mice, E11.5 
and E12.5 embryos were chosen for analyzing the expression pattern of 
Evc. One heterozygous and three homozygous embryos at E11.5 and one 
wild type, one heterozygous, and one homozygous embryo at E12.5 were 
collected and stained with X-gal. Blue stained cells observed only in 
heterozygous and homozygous embryos indicated the region where Evc 
might be expressed. The positive signals in wild-type samples indicated 
endogenous β-galactosidase activity. In the whole mount 
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heterozygous/homozygous embryos, the LacZ positive signal was mainly 
observed around the mouth region as previously shown (Ruiz-Perez et al., 
2007). However, it was difficult to analyze LacZ positive cells in the heart, 
which were in the deep region of the whole mount embryos. 
 
Figure 3.10 X-gal staining at the orofacial region in the Evc+/- embryo 
section 
Whole mount embryos (E12.5) were stained with X-gal and sectioned. The 
X-gal positive cells were observed at the orofacial region in the Evc+/- 
embryo as previously described (Ruiz-Perez et al., 2007). The right panel is 
the enlarged picture of the red squared region in the left panel. Black 
(maxillary process) and blue (mandibular process) arrows indicate positive 
X-gal staining signals. Green and red arrows indicate the stomodeum and 
primitive nasal cavity. Bar: 100 µm 
 
To examine the heart, the X-Gal stained embryos were paraffin wax 
embedded and sectioned into 14µm thicknesses. In the E11.5 embryos, 
faint blue signals were observed at the dorsal side of the atrium wall in 
Evc+/- and Evc-/- samples (Figure 3.11).  
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Figure 3.11 β-galactosidase activity in the heart region in E11.5 mouse 
embryos 
The expression of Evc was detected by the reporter gene lacZ, which 
replaced the exon 1 of Evc gene in Evc+/- and Evc-/- embryos and can be 
detected by X-Gal stain. The blue signals were detected at the dorsal 
region to the atrial wall in Evc+/- and Evc-/- embryos (red arrows). The right 
panel is the enlarged picture of the red squared region in the left panel. Bar: 
100 µm 
 
In the E12.5 embryos, blue signals were observed at the atrial septum in 
Evc+/- and Evc-/- samples, but not in the wild-type samples (Figure 3.12).  
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Figure 3.12 β-galactosidase activity as the reporter of Evc expression 
in the heart region in E12.5 mouse embryos 
To eliminate the contamination of endogenous lacZ expression, the Evc 
expression region defined as the blue cells were only observed in Evc+/- 
and Evc-/- embryos, but not in the wild type embryos. In the region 
presented here, the tiny blue dots were detected in the primary atrial 
septum in Evc+/- and Evc-/- embryos (middle and lower panels, red arrows), 
whereas no blue signal was observed in the primary atrial septum in the 
wild type embryo (upper panel). Bar: 100 µm 
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In the lung bud (Figure 3.13) and gut (Figure 3.14) region, blue signals 
were observed in wild type embryos, indicating the false positive caused by 
endogenous β-galactosidase activity. 
 
Wild-type Evc+/- 
 
 
  
Figure 3.13 Endogenous β-galactosidase activity detected in 
wild-type and Evc+/- E12.5 embryos 
In the right lung bud (accessory lung), β-galactosidase activity was 
detected in wild-type and Evc+/- E12.5 embryos (red arrows). Since no lacZ 
allele was driven by the Evc promoter in wild-type embryos, the blue lacZ 
stain detected in the accessory lung is attributed to endogenous 
β-galactosidase activity. Bar: 100 µm 
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Figure 3.14 X-gal staining of endogenous β-galactosidase activity in 
the E12.5 wild-type embryo 
Endogenous β-galactosidase activity was observed in the caudal extension 
of the hindgut diverticulum and the midgut loop within a physiological 
umbilical hernia. The left panel demonstrates β-galactosidase activity in the 
caudal extension of the hindgut diverticulum (red arrow). In the right panel, 
β-galactosidase activity was detected in the midgut loop within a 
physiological umbilical hernia (red arrow). Bar: 100 µm 
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3.3.2 Undetected Evc mRNA using in situ hybridization 
Since EVC mRNA was detected in the human developmental heart by in 
situ hybridization (Ruiz-Perez et al., 2000), this work analyzed Evc mRNA 
in the mouse heart by in situ hybridization (section 2.7). To examine Evc 
transcripts expressed in the heart region, in situ hybridization on Evc was 
performed. Shh and Ptc probes were used as positive controls in both 
genes expressed in the floor plate, notochord, and gut at E11.5 (Motoyama 
et al., 1998). Although Shh was not detected in the heart at E11.5 
(Goddeeris et al., 2007), Ptc was observed at the dorsal mesenchymal 
protrusion (Goddeeris et al., 2008).  
 
A 
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Figure 3.15 Evc mRNA detected at the tooth bud using in situ 
hybridization 
The tooth bud sections from E13.5 embryo were used as a positive control 
in this study (n=6). Weak Evc positive signals were observed in the 
mesenchymal condensation region around the buds (A). The schematic 
view shows the epithelial cells in light orange and the mesenchymal 
condensation region in red (B). Bar: 100µm 
 
E11.5 wild-type embryos were used in this study. Paraffin wax embedded 
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embryos were sectioned into 7µm thicknesses. Previous studies in our group 
demonstrated Evc protein expression in the teeth bud at E13.5 (Dr. M. 
Nakatomi, in press). E13.5 tooth sections were kindly provided by Dr. M. 
Nakatomi as positive controls (Figure 3.15). 
Sections from E11.5 embryos were first chosen to detect the Evc mRNA in the 
heart region as the atrial septum begins to develop at this stage. Since 
abnormalities in the Shh signaling pathway have been observed in the tooth 
bud region in Evc-/- embryos (Dr. M. Nakatomi, in press), Shh and Ptch1 
probes were applied on the sister sections. In transverse sections of E11.5 
embryos, Shh expression was observed in the floor plate notochord and along 
the digestive tract (Figure 3.16). Ptch1 transcripts were observed near the Shh 
positive regions (Figure 3.17). However, no significant Evc signal was 
observed in sister sections (Figure 3.18). 
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Figure 3.16 Shh mRNA detected in E11.5 mouse embryo section 
Shh transcripts were analyzed in the transverse section of E11.5 mouse embryo 
by in situ hybridization (A) (n=4). Strong signals were observed at the floor plate 
(B, blue arrow) and the notorchord (B, green arrow). No signals were observed 
in the heart region (C). Bar: 500µm 
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Figure 3.17 Ptch1 mRNA detected in E11.5 mouse embryo section
Ptch1 transcripts were analyzed in the transverse section of E11.5 mouse 
embryo using in situ
around the floor plate and the notochord where the Sh
signals were observed in the heart region (C). 
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Figure 3.18 Evc mRNA detected in the E11.5 mouse embryo section
Evc transcripts were analyzed in the transverse section of E11.5 mouse embryo 
(A) (n=4). No Evc signals were observable around the floor plate, notochord (B), 
or in the heart region (representative section, C). 
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Since the Evc transcript was not detected in E11.5 embryos, the serial 
transverse sections of the E9.5 embryo were used following the same 
protocol performed in the E11.5 embryos. Nevertheless, no Evc positive 
cells were observed in these embryos (Figure 3.19). These results 
suggested that Evc mRNA transcripts were either too low to be detected or 
were not expressed at these developmental stages.  
 
A 
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Figure 3.19 Undetected Evc transcript in the heart region in E9.5 
embryos 
Sister sections from the wild-type mouse embryo at E9.5 hybridized with 
Evc antisense probe (n=4). Evc mRNA signals were not observed in the 
heart region. Red arrows indicate the left and right components of the 
common atrial chamber. Blue arrows indicate the bulbo-ventricular canal. 
Bar: 100µm 
 
Evc expression was observed at the dorsal side of the atrium wall (E11.5) 
and the atrial septum (E12.5) during heart development using X-Gal 
staining. However, the Evc transcript was not observable at the heart 
region of E11.5 and E9.5 embryos. This data indicated that Evc expression 
is low or absent at these development stages. 
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3.4 Discussion 
3.4.1 No heart developmental defects were observed in Evc-/- mice 
To verify whether the absence of Evc affects heart development, 
histological analysis was performed in Evc-/- mice and compared with that 
in heterozygous and wild-type littermates. Variations in cardiac morphology 
were observed in Evc deficient mice. However, no significant difference 
was observed between Evc-/-, Evc+/- and the wild-type control (section 3.2). 
The atrial septal defect, a common heart defect in EvC patients, was not 
observed in any of the Evc-/- mice.  
The uncommon features of the heart position and the heart apex were 
observed in 12 out of 25 mice and no significant difference was observed 
between genotypes. These might be artifacts caused during sample 
preparation. To increase penetration of the fixation solution, the thorax 
portion of the mouse was extracted after dissecting out the embryos from 
the uterus. Tissue deformation might have occurred during this procedure. 
Injecting the fixation solution using thin needles might be an alternative to 
increase penetration. However, based on the embryo size and softness, 
even thin needles might damage the tissues. Variations in the degree of the 
ventricular septum muscle and trabeclae were observed in wild-type, Evc+/- 
and Evc-/- mice. No significant difference was observed between genotypes. 
The heart features were scored based on the figures in the book, “The 
Atlas of Mouse Development” (Kaufmann, Revised Edition, 1995). Based 
on the variation among different mouse strains, the unusual features 
defined in this study might be common phenotypes in the mouse with 
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C57Bl/6J-129Sv genetic background.  
The atrioventricular valves in some samples in this study dilated and 
formed a bubble shape structure. This abnormality of the atrioventricular 
valves was observed at a higher occurrence rate in homozygous samples 
(7 of 14) compared to the wild type (1 of 6) or the heterozygous (1 of 5) 
littermate. However, this difference is not statistically significant between 
wild-type/heterozygous and homozygous samples (Fisher’s exact test, 
p=0.2). During heart valve development, the endothelial cells lying at the 
site of the future valves delaminate and protrude into the extracellular 
matrix where they proliferate and differentiate into mesenchymal cells. The 
extracellular matrix and mesenchymal cells undergo differentiation, 
apoptosis and remodeling to form mature valves (de Lange et al., 2004). 
Several studies have reported signaling pathways and proteins to be 
involved in heart valve development including VEGF, NFATc1, Notch, 
Wnt/β-Catenin, BMP/TGF-β, ErbB, and NF1/Ras (de Lange et al., 2004; 
Erickson et al., 1997; Gitler et al., 2003; Kim et al., 2001; Lakkis and 
Epstein, 1998; Miquerol et al., 1999; Ranger et al., 1998; Timmerman et al., 
2004). The bubble shaped leaflet of the atrioventricular valves might result 
from abnormal apoptosis, delayed developmental processes, or other 
unknown mechanisms. Further study is necessary to determine the 
functions of Evc protein in valve development.  
About 60% of EvC patients demonstrate an atrial septal defect. However, 
no defect of the atrial septum was observed in Evc-/- mice in this study. The 
absence of the atrium septum defect might be due to differences between 
mice and humans. Biben and colleagues found that Nkx2-5 deficient mice 
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showed a much milder phenotype in atrial development compared to 
human patients with the same gene deficiency. They found that a similar 
gene, Nkx2-6, expressed at an earlier stage of atrial development, 
compensated for the deficiency in Nkx2-5 in mice (Biben et al., 2000). 
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disease 
with extremely variable phenotypes in human patients. The typical SLOS 
phenotypes are craniofacial malformation, mental retardation, poor growth, 
and structural anomalies of heart, lungs, brain, limbs, and gastrointestinal 
tracts. SLOS results from defects of the DHCR7 protein, which converts 
7-dehydrocholesterol (7-DHC) to cholesterol at the last step of cholesterol 
synthesis. As cholesterol is essential for synthesis of a mature hedgehog 
ligand, perturbed hedgehog signaling might underlie some phenotypes 
observed in patients with SLOS (Cooper et al., 2003). In Dhcr7-/- mice, 
craniofacial malformation and growth retardation were observed, however, 
no significant abnormalities were observed in the heart, kidney, spleen, 
liver, and skeletal structure (Wassif et al., 2001). This suggests that the low 
level of cholesterol is sufficient for development or there might be unknown 
mechanism(s), which compensate in the mouse heart. Thus, Evc in the 
mouse mutant is not unique in failing to display a phenotype observed in 
patients.  
Development of the atrial septum begins at E10.5 and is complete at E13.5 
(Webb et al., 1998). During atrial septum development, the primary atrial 
septum expands from the dorsal side of the atrium wall toward the 
atrioventricular cushion. Meanwhile, the extracardiac tissue penetrates into 
the atrium and the superior portion of this structure follows the primary 
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atrial septum with a mesenchymal cap on its leading edge (Mommersteeg 
et al., 2006). The left-right connection of the atrium closes when the 
extra-cardiac tissue, the primary atrial septum, and the superior 
endocardiac cushion all fuse. Fusion of the atrioventricular endocardial 
cushion separates the left-right atrioventricular connection (Dalgleish, 
1976). Shh signaling from the foregut endoderm is essential for developing 
normal atrioventricular septation. The dorsal mesocardium shows 
abnormal differentiation and migration into the atria when Shh is deficient 
and causes the dorsal mesenchymal protrusion defect which results in 
atrioventricular septation defects (Goddeeris et al., 2008). 
Previous studies have demonstrated that mouse phenotypes are often 
more apparent with an inbred background than with a mixed background. 
Evc-/- mice with C57Bl/6J-129Sv genetic background were backcrossed 
with the inbred strain C57Bl/6J for nine generations. After analyzing three 
litters, no atrial septal defects were observed in Evc-/- mice with an inbred 
C57Bl/6J genetic background. This data suggested that Evc protein is not 
essential for mouse heart development. 
3.4.2 Expression of Evc in heart development  
Approximately 60% of EvC patients have cardiovascular malformations, 
indicating EVC plays a role in heart development. β-galactosidase staining 
positive cells were observed at the dorsal side of the atrial wall and atrial 
septum at the E11.5 and E12.5 stage of Evc-/- embryos (section 3.3.1). 
However, expression was observed in only a small number of cells at these 
embryonic stages and the cell types were not defined. The significance of 
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this study is unclear. Further studies are necessary to define the cell type 
expressing Evc protein at these developmental stages and the functions of 
Evc in these cells.  
Although β-galactosidase staining in Evc-/- is an easy method to analyze 
the expression of Evc protein, this may reflect gene expression at an earlier 
stage of development. Evc mRNA was not detected in the heart in E11.5 
embryos by in situ hybridization (Figure 3.18). The data indicated that Evc 
expression in the mouse heart is minimal and hard to detect by in situ 
hybridization at the earlier time point (E9.5) studied.  
Lipscomb Sund and colleagues detected Evc transcripts at the tip of the 
primary atrial septum with in situ hybridization in wild-type E13.5 mouse 
embryos. Evc transcripts were also observed in the AV cushion, the 
connective tissue of the outflow tract, and the ribs (Lipscomb Sund et al., 
2009). The Lipscomb Sund study used immunofluorescence staining and in 
situ hybridization to determine Evc expression in the heart region. The 
Immunofluorescence staining images indicated positive signals in the 
developing atrial septum. However, other signals with equivalent intensity 
besides those indicated are scattered throughout the same field and not 
mentioned in the text. The region they state to have positive signal regions 
in the in situ hybridization panels are the regions with higher cell density. 
The expression of Evc mRNA in the heart region is still under debate.  
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Figure 3.20 Minimum free energy image generated from the Evc 
mRNA sequence (NM_021292) 1-2730 (due to the limitation of 
prediction program) with Sfold 
2730bp (1-2730) of Evc mRNA sequence was subjected to predict the 
minimum free energy structure with Sfold (A). Three red squares indicate 
both ends of Evc probes used in this study and in the Lipscomb Sund study, 
and the right column shows higher magnificent images. The red arrows in B 
and C indicate the 926 and 1717 position of the predicted mRNA of the Evc 
probe detected in this study. The blue arrows in C and D indicate the 1633 
and 2426 position of the predicted mRNA. 
 
The probes used for in situ hybridization in these two studies are different 
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and could affect sensitivity of this assay. The Evc probe in this thesis was 
designed against the Evc c.926 - c.1717 (length 792 base) based on 
previous tooth bud studies (Dr. M. Nakatomi, personal communication). In 
contrast, Lipscomb Sund et al. used the probe against Evc c.1633 - c.2426 
(length 794 base). When predicting by Sfold (http://sfold.wadsworth.org, 
(Ding and Lawrence, 2003; Ding et al., 2005)), the Evc mRNA was Y 
shaped. The c.926 - c.1717 was located at the compact V head while 
c.1633 - c.2426 was located at the loose tail (Figure 3.20). The folding 
might affect hybridization efficiency in tissues. 
3.4.3 Study of Vangl2 and Evc double knockout mice 
Out of 1,500 Evc breeding mice, one of the Evc+/- mice showed a curved 
tail phenotype, similar to the Vangl2+/- mouse. As the interaction of Wnt and 
Hh is important in development, it is worth tracing if Vangl2 expression is 
able to compensate for the heart phenotype in Evc-/- mice even if the 
recurrent rate is low (~1/1500). Since only Evc-/- mice have shown 
phenotypes and Vangl2 inherits a semi-dominant manner, only 
Evc-/-;Vangl2+/- and Evc-/-;Vangl2-/- mice are valuable for analysis. Two 
double heterozygous female mice were obtained in six litters of Evc+/- and 
Vangl2+/- cross. In theory, 3/16 of the offspring would be either 
Evc-/-;Vangl2+/- or Evc-/-;Vangl2-/-. However, among the nine embryos 
analyzed, none were Evc-/-;Vangl2-/- and one Evc-/-;Vangl2+/- embryo were 
obtained (missing in processing) (Table 3.6). The project was eventually 
abandoned due to time constraints, without reaching a conclusion. The 
possibility that Evc-/-;Vangl2-/- mice are lethal at early embryonic stage 
cannot be excluded.  
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3.4 Conclusion 
Research has detected EVC mRNA in the developing heart by RT-PCR in 
human and 60% of EvC patients have demonstrated heart developmental 
defects (Ruiz-Perez et al., 2000). No significant difference in the occurrence of 
heart variation indicates that Evc might not be involved in the heart 
development in mice or that other protein or mechanisms in the mouse heart 
may compensate for the absence of Evc protein In addition, the protein 
expression study through LacZ reporter analysis showed no differences 
between the heterozygous and Evc-/- mouse. An in situ hybridization study of 
wild-type embryos did not detect Evc transcripts in the heart region. Although 
disappointing and unexpected, these results show that the Evc-/- mouse is not 
a suitable model to study atrial septal defects observed in human patients. 
Therefore, the focus of this program has shifted from cardiac development to 
cell based studies. 
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Chapter 4 Cellular location of Evc and Evc2 proteins 
4.1 Introduction 
4.1.1 Depletion of Ihh signaling in the absence of Evc protein 
Shortening of the long bones and ribs are major features of EvC syndrome. 
Although several signaling pathways are involved in skeletal development, 
Indian hedgehog (IHH) is one of the master regulators (Kronenberg, 2003). 
Furthermore, Evc-/- mice share several phenotypes with mice impaired in 
Ihh signaling, such as epiphyseal shortening caused by chondrocyte 
hypertrophy near to the articular region, defective perchondrium to 
perosteum induction and mineralization of synchondroses, indicating the 
possibility that Evc plays a role in Ihh signaling. The expression of Ihh is 
normal, but expression of Ihh downstream genes Ptch1 and Gli1 was 
markedly decreased in Evc deficient mice (Ruiz-Perez et al., 2007). 
Furthermore, the localization of SMO to primary cilia and GLI3 processing 
is defective in intraflagellar transport mutants (Huangfu and Anderson, 
2005; May et al., 2005). Although cilia are present in Evc-/- chondrocyte, 
western blotting demonstrated that although GLI3 processing appears 
normal, a significant defect downstream of SMO was observed (Ruiz-Perez 
et al., 2007). Taken together, these data suggest that Evc is an intracellular 
component of the hedgehog signal transduction-pathway, required for 
normal transcriptional activation of Ihh target genes.  
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4.1.2 Hedgehog signaling and cilia 
Hedgehog signaling is one of the most vital key regulators involved in 
embryo development. The molecules are important in establishing the 
basis of the body plan and the anterior-posterior body segmentation during 
stages of development. Previous studies demonstrated that Evc protein 
was located at the region around the basal body of cilia (Ruiz-Perez et al., 
2007) which play an essential role in the Hh pathway. In 2007, Caspary and 
colleagues described a lethal mouse mutant, hennin (hnn). The hnn cilia 
mutant showed short cilia with a specific defect in the structure of the ciliary 
axoneme and defects in sonic hedgehog signaling. At E8.0, the 
microtubule doublets were incomplete in the cilia of embryonic nodes of an 
hnn mouse (Caspary et al., 2007). A T-to-G transversion in the splice 
acceptor site of exon 2 of Arl13b gene, encoded for ADP-ribosylation 
factor-like 13B protein. This indicated that the mutation of cilia proteins 
could cause ciliary structural defects.  
 
 
Figure 4.1 Ciliary structure analysis 
in hnn mutant mouse (adapted from 
Caspary et al., 2007) 
The doublets of microtubule in cilia 
from hnn mutant embryos were 
incomplete (red arrow) when 
comparing with the wild-type siblings. 
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4.1.3 Choice of cells 
Since Evc mRNA exists in both bone and kidney, cells isolated from these 
organs are good materials for investigating the function of Evc protein and 
its relationship with cilia and the Hh signaling pathway (Ruiz-Perez et al., 
2007). Herein, we used primary chondrocytes and osteoblasts and a 
mouse inner medullary collecting duct (mIMCD-3) cell line for our 
investigations. Primary chondrocytes and osteoblasts were isolated from 
the tibial epiphyses and calvaria (section 2.8), respectively, of E18.5 mice. 
Evc is most highly expressed at these sites, and is most likely to have 
cellular function. All cells were cultured long enough to obtain sufficient 
cells for the experiments (usually 5-7 days) without further passage. 
Results from this study are compared with results from previous studies of 
the Hh signaling pathway of mouse embryonic fibroblasts (MEF), 
generated from wild type and Evc-/- proteins.  
4.1.4 Deciliation 
Previous studies demonstrated that Evc located around the basal body of 
cilia by immunofluorescence staining (Ruiz-Perez et al., 2007). Since 
proteins located at different cilia sites might play distinct roles (Li et al., 
2010; Zhao et al., 2010; Zhou et al., 2010), precise localization of Evc 
protein might provide clues to its function. Deciliation, which breaks at the 
transition zone, is one approach to understand whether proteins are 
located distal to the transition zone. Several techniques were used for 
deciliation, one reported by Fliegauf (Fliegauf et al., 2006) uses Ca2+ to 
induce the contractio(Zhao et al., 2010)n of centrin, which then severs the 
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cilium at the distal end of the transition zone (Figure 4.2). The reactions 
eventually release the cilium, above the transition zone, into the 
supernatant. The detached cilia are collected by high-speed centrifugation. 
Thus, the location of Evc protein can be determined by 
Immunofluorescence staining on cilia and deciliated cells.  
 
 
Figure 4.2 Transition zone in Elliptio cilium (adapted from Gilula & 
Satir, 1972). 
Longitudinal view of the transition zone (marked as TZ) in Elliptio cilium (A). 
Schematic view of the “champagne glass” structures within the transition 
zone (B). 
 
4.1.5 Aims 
Evc-/- mice share several phenotypes with mice impaired in Ihh signaling, 
for example, epiphyseal shortening caused by chondrocyte hypertrophy 
near to the articular region, defective perchondrium to perosteum induction, 
and mineralization of synchondroses. Moreover, diminished Ihh signaling 
was observed in MEFs generated from Evc-/- mice (Ruiz-Perez et al., 2007). 
In mIMCD-3 cells, Evc protein was located at the region around the basal 
body of cilia, structures that mediate Hh signaling (Ruiz-Perez et al., 2007). 
A B 
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However, the functions of Evc in Hh signaling are still unknown. To 
investigate the function of Evc in Ihh signaling pathway, and cilia formation 
in the absence of Evc proteins, this chapter focuses on refining the 
subcellular localization of EVC protein by deciliation and immuno-TEM. We 
analyze the ciliary structure of chondrocytes from Evc-/- mice using TEM, 
investigate the localization of Evc protein in Evc-/- cells with 
Immunofluorescence staining, and examine the inconsistence of nuclear 
localization between human fibroblasts and MEFs, the detail of which will 
be described in section 4.2.6, by subcellular fractionation assay. 
4.2 Results 
4.2.1 Evc localizes to the region of the cilia transition zone  
Fliegauf (Fliegauf et al., 2006) reported the deciliation protocol optimized 
for human respiratory epithelial cells. However, when following this protocol, 
most of the mIMCD-3 cells became detached from the growth surface. This 
may have been that the solutions used by Fliegauf were too harsh for these 
cells. Consequently, the concentration of deciliation solution and treatment 
time was modified (section 2.9). In the modified method, mIMCD-3 cells 
were treated with the 30mM Ca2+ containing a buffer to induce centrin 
contraction, a component of contractible proteins within the transition zone. 
The contraction severed the cilium at the distal end of the transition zone 
(Figure 4.2). The reactions eventually released the cilium above transition 
zone into the supernatant, and the broken cilia were collected by 
high-speed centrifugation. Immnfluorescent stain (section 2.10) of cilia and 
the deciliated cells then clearly identified the location of Evc protein.  
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To locate cilia more precisely, acetylated tubulin and γ tubulin were used as 
cilium and basal body markers respectively. Since cilia are long linear 
structures, and basal bodies have short tubular structures, the two could 
also be distinguished by shape under fluorescent microscopy. In mIMCD-3 
cells (Figure 4.3, A-C), the cilium protruded out from the membrane. Evc 
protein (Figure 4.3, A) was localized near the basal body as previously 
described (Ruiz-Perez et al., 2007). Cilia were successfully removed from 
the cell surface after deciliation (Figure 4.3, D-I), the basal body (Figure 4.3, 
E, arrows), and a small portion of cilium (Figure 4.3, E, arrowhead), 
remained on the cell. Evc protein was detected on the cell portion, whereas 
no EVC protein was detected in the sheared off cilia (Figure 4.3, G-I). The 
data indicated that EVC protein was mainly located between the basal body 
and transition zone of the cilia.  
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Figure 4.3 Representative figures of deciliation treatments of 
mIMCD-3 cells 
mIMCD-3 cells both with and without deciliation treatment were detected 
with Evc antibodies (red panel), acetylated tubulin (marker of axoneme, 
green panel), and γ-tubulin (marker of centrioles/basal body, green panel) 
(n=3). The faint blue signal indicates a nucleus marked by DAPI (blue, C 
and F). The upper row (A, B, C) represents cells without deciliation 
treatment. The EVC protein (A, white arrow) was localized to the base of 
cilium. The middle row represents the cell after deciliation treatment. EVC 
protein was detectable in the cells after deciliation treatment (D, white 
arrow). The γ-tubulin composed daughter centriole and the basal body (E, 
white arrows) and a small part of axoneme (E, white arrowhead) appeared 
in the treated cell. The lower row represents the sheared-off cilium. No Evc 
protein was observed on the sheared-off cilia (G). The absence of DAPI 
stain (I) indicated that the cilium signal did not come from the cell debris. 
Bar: 5µm 
EVC 
A                     B                     C 
D                     E                     F 
G                     H                     I 
Acetylated and γ tubulin merge 
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Following deciliation, only acetyl-tubulin was observed at sheared-off cilia. 
It is doubtful that the linear structure shown at Figures 4.3, H was true 
cilium. Therefore, verification of the sheared off cilia by another 
cilia-specific protein became necessary. Sufu is a component in the 
hedgehog pathway, and is expressed at the tip of cilia when the hedgehog 
pathway is activated (Haycraft et al., 2005). Treatment of mouse mIMCD-3 
cells with purmorphamine for 72 hours activated the hedgehog pathway. 
Prior to deciliation, Sufu was observed at the cilium tip prior to deciliation, 
and after treating with purmorphamine (Figure 4.4, D, arrow), but not 
following treatment with DMSO alone (Figure 4.4, A).  
 
   
   
Figure 4.4 Representative figures of localization of Sufu in 
purmorphamine treated mIMCD-3 cells 
MIMCD-3 cells treated with DMSO (upper row) or purmorphamine (lower 
row) were detected with antibodies against both Sufu (green panel), and 
acetylated tubulin (red panel) (n=3). Use of DAPI countered stained nuclei. 
Sufu was not found at the tip of cilia following treatment with DMSO (A). 
Sufu protein accumulated at the tip of cilium after treating with 
purmorphamine for 72 hrs (lower row). Bar: 5µm 
Sufu               Acetylated tubulin             merge 
A                      B                       C 
D                      E                       F 
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mIMCD-3 cells were treated with purmorphamine for 72 hours, deciliated, 
and triple immunofluorecent stained for Evc, acetylated tubulin and Sufu. 
Figure 4.5.A through D shows the cell without deciliation treatment, and 
both EVC (Figure 4.5, A, arrow) and Sufu (Figure 4.5, C, arrow) could be 
observed. After deciliation (Figure 4.5, E through H), Evc (Figure 4.5, E) 
and small portion of acetylated tubulin (Figure 4.5, F, arrow) was observed, 
demonstrating successful deciliation. Figure 4.5, I through L, demonstrated 
immunofluoresecent stain on the putative sheared-off cilia (Figure 4.5, J). 
However, a Sufu signal was not detected in the linear structure (Figure 4.5, 
K). The undetectable Sufu signal might results from disruption of cilia 
structure during deciliation procedure. 
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Figure 4.5 Representative figures of deciliation of purmorphamine 
treated mIMCD-3 cells 
Purmorphamine treated mIMCD-3 cells stained with antibodies detected 
Evc (red panel), acetylated tubulin (blue panel, as a marker for cilium), and 
Sufu (green panel) (n=3). Without deciliation treatment, Evc was localized 
to the base of cilium (A, white arrow) and Sufu was localized to the tip of 
cilium (C, white arrow). After deciliation treatment, Evc (E, white arrow) and 
a small portion of cilium (F, white arrow) remained localized to cells. No 
Sufu signals were observed in deciliated cells (G). No Evc proteins were 
observed on the sheared-off cilium, (I). However, there were no Sufu 
signals on collected sheared cilia (K). Bar: 5µm 
4.2.2 Failure to detect Evc protein by immuno-TEM 
To further refine the location of Evc protein, mIMCD-3 cells were examined 
using immuno-TEM (section 2.11). The immuno-TEM method is reported to 
determine the subcellular localization of other cilia and basal body proteins 
successfully (Paoletti et al., 1996). Initially, we used the same staining 
EVC        Acetylated tubulin       Sufu            merge 
A                B                C                D 
E                F                G                H 
I                 J                K                L 
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method as for Immunofluorescence staining. Figure 4.6 shows that cilia 
morphology is not good following this protocol. It is likely that this is due to 
the detergents, triton X-100, and between 20, which were used in the 
staining steps. The structure of the basal bodies was unseen using this 
protocol. 
 
 
Figure 4.6 Ciliary structure 
observed after detergent 
treatment in pre- and 
post-staining samples. 
The cilium-like structure was 
destroyed during 
immunofluorecent staining (n=3). 
This may have been due to 
sensitivity to the detergent, which 
was applied in order to penetrate 
the cell membrane and allow the 
entrance of the primary antibody. 
Bar: 500nm 
  
  
To preserve morphology, immuno-TEM followed a modified protocol 
without using detergent. The cilium morphology appeared unmistakably 
and basal bodies were found following the detergent-free protocol. 
Clustered gold particles were located to the base of cilium (Figure 4.7, A, 
red arrow). However, gold particles also grouped in clusters with no 
apparent relation to any organelle (Figure 4.7, B, red arrow) or even 
outside the cell (Figure 4.7, C, red arrow). Single gold particles were 
randomly scattered both inside and outside the cell (Figure 4.7, D, red 
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arrows). Some basal bodies did not have associated gold particles (Figure 
4.7, E). Based on these observations, gold particle staining in this 
immuno-TEM protocol was non-specific, and this experiment failed to 
provide the precise localization of Evc protein. 
A 
 
D 
 
B 
 
C 
 
E 
 
Figure 4.7 Transmission electron micrographics of cilium stain for 
Evc 
Cells treated without detergent underwent the immuno-TEM experiment 
(n=3). Blue lines indicate the centriole structure (basal body in A and E, 
basal body or daughter centriole in B and D). Clustered gold particles 
occurred around the basal body (A, red arrow). However, the gold particles 
clustering occurred in the absence of any organelle (B, red arrow), or 
outside the cell (C, red arrow). Some gold particles were randomly 
scattered (D, red arrows). Some cilia were without any gold particles 
nearby (E). Bar: 100nm 
4.2.3 Normal ciliary structure in Evc-/- mouse chondrocytes 
Mutation of genes encoding ciliary proteins might lead to the defects of 
ciliogenesis. To test whether the ciliary structure was affected in the 
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absence of Evc protein, chondrocytes isolated from E18.5 embryos of wild 
type and Evc-/- mice were used as subjects for ciliary inner structure 
observation. Initially, sample preparation followed Newcastle University’s 
electron microscopy unit, standard protocol.  
 
A 
 
B 
 
C 
 
D 
 
E 
 
Figure 4.8 Representative figures of ciliary structures observed in 
sections generated with perpendicular cutting plane 
With a vertical cutting plane, cilia were usually found in sagittal sections 
(Frames A and B) (n=3). Basal bodies and/or daughter centrioles were also 
observed (C, D, and E). Bar: 100nm  
In this protocol, the cutting plane is perpendicular to the culture membrane 
(Figure 4.9, purple dotted lines). During analysis of 20 grids with sections 
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generated from Evc-/- chondrocytes, we found some cilia related structures. 
These generated sagittal sections of cilia or basal body/daughter centriole 
(Figure 4.8). To obtain transverse sections of cilia, we changed the cutting 
plane from the perpendicular, to parallel to the membrane (Figure 4.9, red 
dotted lines). 
 
Figure 4.9 Schematic view of the cutting strategy.  
Light yellow box indicates the embedding material, cells (light blue) 
cultured on membrane (light green). The purple dotted lines indicate the 
initial cutting strategy, perpendicular to the membrane, while the red dotted 
lines indicates the modified cutting strategy which parallel to the 
membrane. 
 
Twenty grids with sections from wild type chondrocytes and 20 grids with 
sections from Evc-/- chondrocytes were analyzed. To obtain clear 
information on the structure of cilia in the absence of Evc, only cilia that 
could be traced in at least six sequential sections were analyzed. Most of 
the cilia observed were limited to the basal body/daughter centriole or were 
less than five transverse sections. In total, three cilia from wild type and two 
cilia from Evc-/- met the criteria. 
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The longitudinal section of cilia (Figure 4.10, A) showed the two main 
portions of cilium, the basal body region and the ciliary region. The red lines 
represent the approximate positions of each transverse section (Figure 
4.10, B, and C). In figure 4.10 B, the upper two rows of sections 
demonstrate that both wild type and Evc-/- mouse chondrocytes may 
contain disorganized doublets wild type (red arrowheads). In the third row, 
sections crossed the cilia, and showed nine doublets of microtubules. The 
champagne glass structure (green arrowheads) connecting the doublet to 
the ciliary membrane was a specific structure in the cilia transition zone. In 
figure 4.10, each frame in row C shows nine triplets of microtubules and a 
spiked structure connecting the basal body and plasma membrane (blue 
arrow). All observed cilia show complete triplet microtubule structures in 
the proximal region and doublets in the ciliary region (Figure 4.10, B). 
There were no structural differences between cilia from wild type and Evc-/- 
chondrocytes. Comparison of Evc-/- chondrocytes with the wild type cilia 
found no structural defects in the former. Kiprilov previously reported the 
circle of disorganized doublets in the distal regions of cilia in wild type cells 
(Kiprilov et al., 2008). 
 
 
 
 
 
 
   
A 
 
B
  
  
 C
Figure 4.10 Representative figures of l
sections of chondrocyte cilia. 
The longitudinal section (frame 
position of the transverse sections seen in frames B and C
shows transverse sections of cilia from wild type and 
genotypes, disorganized doublets were found in the distal regio
arrowheads) and the champagne glass structures were found in the 
proximal region (green arrowheads). Nine triplets’ microtubules and spiked 
structures (C, blue arrowheads) were visible in transverse sections of the 
basal body. Bar: 100nm.
4.2.4 Mis-localization
A Yeast-two-hybrid study demonstrated that E
interaction proteins, and that both E
primary cilia (Dr. S. Tompson, personal communication). To verify the 
localization of Evc2 protein in the absence of E
Immunofluorescence
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Wild-type 
Cilium 1     Cilium 2 
Evc
Cilium 1    
 
 
 
 
 
  
 
  
ongitudinal and transverse 
 
A) and red lines indicated the approximate 
 (n=3)
Evc-/- cells. In both 
 
 of Evc2 in the absence of Evc protein
vc2 is one of the E
vc and Evc2 are present at the base of 
vc protein, 
 staining for Evc2 was performed on MEFs, 
-/-
 
Cilium 2 
  
  
  
  
. Frame B 
n (red 
 
vc 
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chondrocytes and osteoblasts were generated from Evc-/- mice and 
compared to wild type cells. Evc2 was present at the base of cilia in three 
types of cells generated from wild type mice (Figures 4.11, 4.12 and 4.13). 
However, no Evc2 signals were detected at the base of cilia in Evc deficient 
cells (Figures 4.11, 4.12 and 4.13). 
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4.2.5 Evc2 protein in Evc-/- cells 
There are two possible reasons for the absence of Evc2 at the basal body 
in Evc-/- cells.  
1. Evc2 is absent in these cells.  
2. Correct localization of Evc2 is Evc dependent.  
To distinguish these two possibilities, total protein was extracted from both 
wild type and Evc-/- MEFs and analyzed by western blot. The specificity of 
the Evc2 antibody was verified by incubating with specific blocking peptide. 
Similar intensities of the loading control, actin, showed in both wild type and 
Evc-/- cells. Evc2 signals were observed in both wild type and Evc-/- cells, 
whilst no Evc2 signals were detected after incubating with blocking peptide 
(Figure 4.14). The data indicated the transcription and translation of Evc2 
proteins were unaffected in the absence of Evc protein. 
 
 Wild type Evc-/- Wild type Evc-/- 
Evc2 
 
blocking peptide 
ACTIN 
Figure 4.14 Western Blot analysis of Evc2 protein in Evc-/- MEF 
Western blotting analysis of total protein extracted from MEF and Evc2 
protein (~160kDa) were present in both wild type and Evc-/- MEF (n=4). No 
Evc2 proteins were detected when antibodies were pre-incubated with a 
specific blocking peptide. Actin (~55kDa), used as a loading control, 
demonstrated that the loading volumes were approximately equivalent. 
 
This supports the second hypothesis, that Evc2 ciliary localization is Evc 
dependent. 
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4.2.6 Subcellular fractionation localization of Evc and Evc2 
In human fibroblasts, as in MEF, EVC protein is present at the base of 
cilium. Anti-human-EVC antibody, designed against human EVC-protein 
amino acid 235 – 952, was purified by antigen affinity purification. Antigen 
blocking analysis successfully demonstrated specificity. When human 
fibroblasts were transfected with GFP tagged EVC, immunofluorecent 
antibody staining showed the co-localization of GFP and EVC. An EVC 
protein signal arose from nuclei where no Evc signal was present in mouse 
cells (Dr. H Blair, personal communication) (Figure 4.15). Similar 
differences in mouse and human proteins were reported for other proteins, 
such as Werner helicase (Suzuki et al., 2001). This discrepancy of the 
nuclear localization of EVC protein in human and mouse cells led to the 
question whether Evc protein is located in mouse nuclei even though it was 
undetected by immunofluorecent staining. To test the possibility, MEF 
underwent a subcellular fractionation experiment (section 2.12) and the 
fractions analyzed by western blotting (section 2.13). 
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Human fibroblast 
EVC Acetylated tubulin merge 
Mouse MEF 
Evc Acetylated tubulin merge 
Figure 4.15 Representative figures of immunofluorecent staining 
detecting EVC in human fibroblasts and MEFs 
Human fibroblasts stained for human EVC protein antibody (Dr. H Blair, 
personal communication). The EVC protein (red) were located at the base 
of cilia (green, acetylated tubulin) and detected within in the nuclei (blue in 
merge, DAPI). In MEFs, Evc protein (red) was detected at the base of cilia 
(green, acetylated tubulin). No specific signals of Evc occurred in MEF 
nuclei. Bar: 5µm 
 
Seven cytoplasmic fractions were obtained from the supernatant by gentle 
sequential lysis of MEF plasma membrane generated from wild type and 
Evc-/- mice. The remaining pellet was treated with lysis buffer, and the 
supernatant harvested as the nuclear fraction. Evc and Evc2 protein 
expression was analyzed by western blotting, whilst α-tubulin and c-Jun 
were used as cytoplasmic and nuclear markers respectively (Murakami et 
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al., 1991; Obungu et al., 2003; Oni, 2002). In both wild type and Evc-/- MEF, 
fraction 7 produced no α-tubulin signals, indicating the complete lysis of 
plasma membrane. No cytoplasmic protein carried into the nuclear fraction 
(Figure 4.16). 
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Figure 4.16 Representative figures of western blotting analyses of 
subcellular fractionations from both genotypes of MEFs (I) 
Seven cytoplasmic fractions and one nuclear fraction were detected with 
Evc (~130kDa), Evc2 (~160kDa) and γ-tubulin (~55kDa) (n=5). α-tubulin 
(~55kDa) and c-Jun (~48kDa) were used as fraction markers. Evc signals 
appeared in almost all fractions from wild type MEF and was not found in 
Evc-/- MEF. Evc2 appeared in several fractions though the strongest signal 
appeared in the C3 fraction. 
 
As reported previously, the centrile protein, γ-tubulin, was observed in the 
cytoplasmic (Figure 4-16, C1~C5) and nuclear (Figure 4-16, N) fractions. In 
wild type, both Evc and Evc2 proteins were present in cytoplasmic and 
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nuclear fractions. The nuclear fraction of Evc-/- mouse MEF contained no 
Evc protein. Data in Figure 4.17 established that Evc2 expression is 
unchanged in Evc-/- mouse MEF. Since it is difficult to accurately analyze 
chemoluciferase intensity in different western blot membranes, the 
selected fractions were prepared on the same membrane used for western 
blotting. 
 
 Wild type Evc-/- 
 C1 C2 C7 N C1 C2 C7 N 
Evc2 
 
α-tubulin 
c-Jun 
 
Figure 4.17 Representative figure of western blotting analysis of 
subcellular fractionations from both genotypes of MEFs (II) 
C1, C2, C7, and N fractions from both genotypes of MEFs contained Evc2 
antibody (Y-20) (n=5). Evc2 signals appeared in all fractions, except for C7. 
α-tubulin (~55kDa) and c-Jun (~48kDa) were also detected as cytoplasmic 
and nuclear fraction markers respectively. 
 
4.2.7 Distribution pattern of SNX5 and SNX6 
A yeast two-hybrid study by our group demonstrated the interaction of Evc 
with Snx5 and Snx6 (Dr. S. Tompson, personal communication). Sorting 
nexins are a large group of proteins containing a phospholipid-binding (PX) 
domain. Some members of the sorting nexin family are involved in 
intracellular trafficking (Wassmer et al., 2007). To investigate whether the 
localization of Snx5 and Snx6 alter in the absence of Evc, the distribution of 
Snx5 and Snx6 were analyzed by western blot in the same fractions as 
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analyzed figure 4.16 and presented in figure 4.18. Snx5 and Snx6 were 
present in cytoplasmic and nuclear fractions. Although the nuclear 
expression of Snx5 has not been reported, Snx6 has been observed in the 
nucleus in another study (Ishibashi et al., 2001). Therefore, the faint signals 
seen for Snx5 and Snx6 in nuclear fractions might not be contamination 
from cytoplasmic fractions. Snx5 and Snx6 showed the same distribution 
pattern in both wild type and Evc-/- MEFs. This data indicated that 
localization Snx5 and Snx6 was not altered in absence of Evc protein. 
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Figure 4.18 Representative figures of western analyses of Snx5 and 
Snx6 in fractions 
Subcellular fractionations from both genotypes of MEFs were detected with 
Snx5 (~51kDa) and Snx6 (~50kDa) antibodies to analyze the distribution 
pattern of these two proteins (n=5). The distribution patterns of Snx5 and 
Snx6 were similar when compared to wild type and Evc-/- MEF. This pattern 
mirrored that for α-tubulin, which showed the strongest signal in C1 and 
decreased in intensity gradually through the remaining fractions. 
 
 
 
 
 
 
 
119 
 
4.3 Discussion 
4.3.1 Evc localizes between the basal body and the transition zone of 
cilia and in the nucleus of human MEF 
Previous reports from our group highlighted the hedgehog signaling defect 
in Evc-/- mice, and localized Evc proteins to the basal region of cilia 
(Ruiz-Perez et al., 2007). However, immunofluorescence staining is a 
relatively low-resolution method. The precise localization of Evc protein 
might provide a clue to the function of Evc. Herein, we used the deciliation 
method, which breaks cilia at the distal end of the transition zone, leaving 
the transition zone and basal body connected with the cell. 
Immunofluorescence staining demonstrated that Evc was only located at 
the cell site, and not in the sheared off cilia (Figure 4.3 & 4.4). These data 
indicated that Evc protein was mainly located between the basal body and 
transition zone of the cilia. Immuno-TEM was also used to investigate the 
localization of Evc protein in mIMCD-3 cells. However, the cells are fragile 
and the cilia structure was destroyed by treatment with triton X-100 or 
Tween-20. No signal was detected using a gentle permeabilizing protocol. 
In a detergent free experiment, signals were seen; however, they might 
result from non-specific binding. It is possible to improve the staining 
method in several ways, such as using cryosections, or modifying the 
embedding materials. However, Evc protein was specifically located to the 
region between the basal body and the transition zone by deciliation 
experiments, and many proteins with diverse functions are in this region, 
around the basal body of primary cilia.  
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Although not detected in mouse cells, EVC is present in the nucleus of 
human MEF as demonstrated by immunofluorescence staining. Subcellular 
fractionation followed by western blot analysis confirmed the expression of 
Evc in the nuclei of mouse MEF. The apparent discrepancy may result from 
sensitivity differences between the two methods. Western blot with 
detection by an ECL kit is known to be a sensitive method for proteomic 
studies (1-10 ng, according to ECL commercial catalog) whilst conventional 
immunofluorescence staining used in this study is less sensitive, detecting 
10-100 ng protein (Bulinski and Borisy, 1980). Examination of the signal by 
microscope makes immunofluorescence staining useful for obtaining 
information on the localization of the proteins of interest. Furthermore, 
immunofluorescence staining sensitivity can be improved 5 to 1000 fold 
using the tyramide signal amplification (TSA) technique (Loup et al., 1998).  
4.3.2 Inner structure of cilium from Evc-/- chondrocyte 
Since there are no functional domains observed in Evc protein, it is difficult 
to predict the function of Evc. In this study, the presence of primary cilia in 
chondrocytes and MEFs from Evc-/- mice indicates that Evc might not be 
required for the formation of cilia. Deciliation followed by 
immunofluorescence staining localized Evc protein between the basal body 
and the transition zone of cilia. Further research into Evc function is 
necessary. Since the dysfunction of ciliary proteins might cause a failure of 
ciliogenesis or a defect of the substructure of cilia (Blacque et al., 2004; 
Ferrante et al., 2006), the presence of primary cilia were first analyzed. The 
presence of primary cilia in chondrocytes and MEF cells from Evc-/- mice 
demonstrated the non-essential nature of Evc protein in the formation of 
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cilia. Furthermore, other research data indicated that defects of ciliary 
proteins might affect cilia morphology. Caspary and colleagues described a 
lethal mouse mutant, hennin (hnn) with short cilia and a specific defect in 
the structure of the ciliary axoneme in 2007 (Caspary et al., 2007).  
We analyzed ciliary structure in the absence of Evc protein. We used 
transmission electron microscopy (TEM) to examine cilia from wild type, 
and Evc-/- chondrocyte. TEM is a sensitive technique where cellular and 
subcellular structures are viewed in detail. Since cilia are small and fragile 
structures and generally reduced in number and length during TEM 
preparations (Heller and Gordon, 1986), only cilia which could be observed 
for 6 serial sections were used for further analysis, in order to eliminate 
artifacts caused by mishandling. Moreover, correct orientation is necessary 
to view specific structure within cilia. The TEM method is a time consuming 
and expensive technique (Ferris et al., 2002), and only 5 reliable cilia, 
meeting our criteria, were observed. All observed cilia showed nine 
well-organized doublets of microtubules at the proximal end (Figure 4.10). 
At the distal end of cilia, disorganized microtubules were present both in 
chondrocytes from wild type and Evc-/- mice. Such disorganized structures 
have been previously reported by Kiprilov and colleagues in normal human 
embryonic stem cells (Kiprilov et al., 2008). There were no obvious defects 
of the inner structure of Evc-/- chondrocytes cilia. Analysis of more cilia 
might be a first priority to understanding the effect of Evc deficiency in cilia 
structure. Moreover, the length and shape of cilia from Evc-/- mice were not 
precisely analyzed in this study. The involvement of Evc protein in 
ciliogenesis is still not established. 
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Mutant ciliary proteins altered the generation/length and shape of cilia. 
Kif3a, components of the Kinesin motor complex, and Tg737, a component 
of intraflagellar transport, are responsible for the loss/shortening of cilia 
when disrupted (Lin et al., 2003; Pazour et al., 2000). Mutant 
tetratricopeptide repeat-containing hedgehog modulator-1 (THM1) could 
cause a bulb-like structure at the distal tips of cilia (Tran et al., 2008). In this 
study, we examined only the cilia inner structure and the possibility that Evc 
protein might function in ciliogenesis still exists. 
4.3.3 Precise localization of Evc2 protein is Evc protein dependent 
The interactions of Evc and Evc2 proteins were clarified by results from 
yeast-two hybrid studies (Tompson S. et al., paper in preparation). The 
interacting proteins usually affect the stability (Thelin et al., 2007), protein 
activity (Gravel et al., 1977), correct localization, or transportation 
(Ishibashi et al., 2001). To understand the interactions between two 
proteins, Evc2 proteins were analyzed in wild type and Evc-/- mouse MEFs 
by western blotting and Immunofluorescence staining. Evc2 proteins were 
expressed at the base of the cilium in wild type MEF, but no Evc2 protein 
signal was seen for Evc-/- MEF (Figure 4.11, 4.12 & 4.13). Mouse Evc-/- 
chondrocytes and osteoblasts confirmed these observations. Furthermore, 
the quantity of Evc2 proteins did not affect in the total lysate of Evc-/- MEFs 
during western blotting analysis (Figure 4.14). The data indicated that 
instead of affecting the stability of Evc2 proteins, the precise localization of 
Evc2 protein might be Evc protein dependent.  
Subcellular fractionation was used to analyze the subcellular localization of 
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Evc2 protein in wild type and Evc-/- cells. In some experiments, the Evc2 
protein is low and difficult to be detected in both wild-type and Evc-/- cells 
(figure 4.16) which might be caused by the cell condition in culture. In 
general, subcellular studies show that Evc2 was present in the cytosol and 
nuclear fractions both in wild type and in Evc-/- mouse MEF. The data 
suggested that the Evc2 protein is present in cytosol even in the absence of 
Evc proteins. Since immunofluorescence staining can only detect proteins 
with more than 100 copies present, the absence of an Evc2 signal from 
Evc-/- cells indicated that the Evc2 is dispersed in the cytosol. The 
determination of Evc2, in the absence of Evc protein, should depend on 
high sensitivity methods, such as immuno-TEM or sucrose gradient. 
4.3.4 The general distribution of Snx5 and Snx6 was unaffected by the 
absence of Evc 
Other then Evc2, Snx5, and Snx6 interaction was also suggested by yeast 
two-hybrid analysis (Dr. S. Tompson, personal communication). The 
results from section 4.2.4 demonstrate that the precise localization of Evc2 
is Evc dependent. It is interesting to consider whether Evc would affect the 
localization of other interacting proteins, such as Snx5 and Snx6. We used 
a general test for the localization of Snx5 and Snx6 on subcellular 
fractionation (Figure 4.18). Merino-Trigo reported the transportation of 
Snx5 in cytosol (Merino-Trigo et al., 2004) whilst Ishibashi et al. 
demonstrated that Snx6 was localized in both the cytosol and in the 
nucleus (Ishibashi et al., 2001). Snx6 was present in the cytosol and 
nucleus of wild type and Evc-/- cell fractions. We observed Snx5 to be 
present in cytosol and nuclear fractions in wild type and Evc-/- cells. The 
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general localization of neither Snx5 nor Snx6 altered in the absence of Evc 
protein. Only cytosol and nuclear fractions were of interest in the 
subcellular fractionation. Disturbed localization of these two proteins in 
small organelles cannot be excluded, as Snx5 was translocated from 
endosome to cell membrane in the EGF stimulation. Further studies, such 
as the trace of GFP or tag fused Snx5 or Snx6 protein, are necessary to 
address the effects of Evc on Snx5 and Snx6.  
4.4 Conclusion 
Evc and Evc2 are unique proteins, which do not share known functional 
domains with any other proteins. We identified Evc protein localization as the 
cilia basal body-transition zone. Although the functions of Evc and Evc2 are 
unclear, the immunofluorescence staining study demonstrated that the correct 
localization of Evc2 protein is Evc dependent. Furthermore, Evc and Evc2 
were present in nuclei, in addition to their presence at the base of cilia. 
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Chapter 5 Discussion 
5.1 Summary of achievement for this thesis 
A review of the aims of this thesis proposed in Chapter 1, and relisted below, 
reveals that progress has been made on all aims.  
 
STATEMENT OF AIMS 
− To analyze heart development in Evc-/- mice (chapter 3) 
− To characterize Evc expression in the heart development of mice 
(chapter 3) 
− To determine the precise localization of Evc protein in cells (chapter 4) 
− To verify the ciliary structure of Evc-/- cells (chapter 4) 
− To verify subcellular distribution of potential Evc interacting proteins in 
Evc-/- cells (chapter 4) 
 
Histological analysis of the heart in the absence of Evc was performed. In the 
chapter 3 in this thesis, no significant difference in the occurrence rate of the 
variations observed between Evc-/- and wild type embryos was demonstrated 
(Table 3.3). Cells positive for LacZ, a reporter gene of Evc expression in Evc+/- 
and Evc-/- mice, were observed on the dorsal side of the atrium wall in E11.5 
as well as the atrial septum in E12.5 embryos (section 3.3.1). However, the in 
situ hybridization did not reveal gene expression (section 3.3.2). This implied 
that levels of expression were low, the method was not sensitive enough to 
detect expression in a small number of cells, or that LacZ reflected earlier gene 
expression. These data also indicated that Evc is not essential for heart 
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development or that other proteins or mechanisms can compensate for Evc in 
mice.  
Evc localization was limited to an area between the basal body and the 
transition zone (section 4.2.1). No significant defects of the ciliary structure 
were observed in Evc-/- chondrocytes.  
This study has conclusively shown that correct localization of Evc2 is Evc 
dependent (section 4.2.4 & 4.2.5). The presence of Evc in the nucleus of MEFs 
was also confirmed.  
5.2 Strengths of the work 
Evc and Evc2 proteins are unique proteins, which do not share known 
functional domains with any other proteins. At the beginning of this project, 
knowledge of EvC syndrome was limited to its definition - an autosomal 
recessive disease caused by mutations in either the EVC or EVC2 gene. Evc-/- 
mice revealed a similar phenotype to human EvC syndrome in skeletal 
development. Ihh signaling was diminished in these mice. A thorough study of 
heart structure was undertaken, but no malformations were observed in Evc-/- 
mice. Although complete ablation of Shh signaling leads to defects in heart 
development in mice, it appears that the developing mouse heart is able to 
compensate for signaling modulation in the Evc mutant. 
Correct localization of the Evc protein should prove useful for understanding 
protein function. Due to time constraints and technical difficulties, it was not 
possible to improve the immuno-TEM enough to obtain the precise localization 
of the EVC protein. The results were inconclusive due to the relatively low 
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resolution of immunoflurorescence staining in deciliation studies. Clearly, 
further optimization of immuno-TEM is required to address the precise 
localization of the Evc protein.  
The interaction of Evc and Evc2 was first detected by using yeast two-hybrid 
screen in our group. This interaction was then confirmed by 
co-immunoprecipitation (Dr. S. Tompson, personal communication).In this 
study, the immunofluorescence staining, which demonstrated the 
mis-localization of Evc2 proteins in Evc deficient MEFs, confirmed the 
hypothesis. Furthermore, an important outcome of this thesis was that Evc2 
protein localization is dependent on the Evc protein. 
5.3 Limitations of the work 
Due to time constraints and technical difficulties, immuno-TEM did not 
determine the precise localization of the Evc protein in cilia. It was 
disappointing that localizing the Evc to the region between the basal body and 
the transition zone by immunofluorescence staining after deciliation did not 
provide enough information on the function of the Evc protein. As mouse EVC 
antibody worked successfully in immunofluorescence staining, one possible 
reason for the failure of immuno-TEM could be the masking of epitopes during 
sample preparation. Clearly, further optimization of immuno-TEM procedures 
is necessary to be successful.  
5.4 Prospective future work to address the functions of Evc 
5.4.1 Optimization of methods used in this study 
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Localization in the same subcellular compartment is necessary for 
interacting proteins to co-operate towards a common biological function. 
Therefore, native subcellular localization of a protein is important for the 
understanding of its function (Nair and Rost, 2003). Precise localization of 
Evc and Evc2 proteins at the base of cilia may shed light on their functions. 
It is disappointing that the immuno-TEM did not provide a result. Further 
attempts to optimize immuno-TEM are worth pursuing. Further studies can 
focus on permeabilization by gentle methods and blocking with rabbit or 
sheep serum. Alternation of concentration and incubation times of primary 
and secondary antibodies may provide another method for stain 
improvement.  
5.4.2 Evc2-/- mice and cells 
Recently, our group has generated an Evc2 knockout mice, which provides 
a great resource for investigating the pathomechanism of EvC syndrome. 
Histological analysis of heart development in Evc2 knockout embryos is 
necessary. The expression of Evc2 during heart development should be 
further analyzed. Moreover, analysis of heart development in Evc and Evc2 
double knockout may provide a clue to the functions of these two proteins.  
In this study, the mis-localization of Evc2 was observed in Evc-/- MEFs. This 
indicated that the correct localization of Evc2 is Evc protein dependent. 
Further research of interest would be the use of Evc2-/- cells to determine 
whether Evc localization is Evc2 dependent.. Immunofluorescence staining 
could be performed to address this.  
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5.4.3 Protein profile in Evc-/- cilia 
No morphological changes were observed in the structure of the cilia in 
Evc-/- MEFs compared to wild-type cells. However, the possibility that some 
proteins are lost by absence of Evc is not excluded. Herein, it is vital to 
analyze the protein contents of Evc-/- cilia. The cilia can be collected by the 
deciliation method presented in this thesis. Proteomic studies follow cilia 
collection. . Two-dimensional gel electrophoresis is a reliable technique 
used to identify different proteins between wild type and Evc-/- cells. 
Different regions can be isolated from electrophoresis gels and then 
analyzed by mass spectrometry.  
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